<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"
        "http://www.w3.org/TR/html4/loose.dtd">
<html lang='en'>
<head>
<body>

<div class="frontpage"><spacer type="vertical" size="30">
<h1><font size="+1">EUKARYOTIC PROMOTER DATABASE USER MANUAL
<br>Written by: Philipp Bucher, Rouaida Cavin P&eacute;rier, Viviane Praz and Christoph Schmid</font></h1>
EPFL School of Life Sciences - SV
<br>
and Swiss Institute for Experimental Cancer Research - ISREC
<br>
Computational Cancer Genomics Group
<br>
EPFL SV ISREC GR-BUCHER Station 15
<br>
CH-1015 /Lausanne
<br>
Switzerland
<p>Electronic mail:
</p>
<address><script>eval(unescape('%66%75%6E%63%74%69%6F%6E%20%73%65%62%5F%74%72%61%6E%73%70%6F%73%65%32%31%32%33%28%68%29%20%7B%76%61%72%20%73%3D%27%61%6D%6C%69%6F%74%61%3A%6B%73%65%2D%64%70%67%40%6F%6F%6C%67%67%65%6F%72%70%75%2E%73%6F%63%6D%27%3B%76%61%72%20%72%3D%27%27%3B%66%6F%72%28%76%61%72%20%69%3D%30%3B%69%3C%73%2E%6C%65%6E%67%74%68%3B%69%2B%2B%2C%69%2B%2B%29%7B%72%3D%72%2B%73%2E%73%75%62%73%74%72%69%6E%67%28%69%2B%31%2C%69%2B%32%29%2B%73%2E%73%75%62%73%74%72%69%6E%67%28%69%2C%69%2B%31%29%7D%68%2E%68%72%65%66%3D%72%3B%7D%64%6F%63%75%6D%65%6E%74%2E%77%72%69%74%65%28%27%3C%61%20%68%72%65%66%3D%22%23%22%20%6F%6E%4D%6F%75%73%65%4F%76%65%72%3D%22%6A%61%76%61%73%63%72%69%70%74%3A%73%65%62%5F%74%72%61%6E%73%70%6F%73%65%32%31%32%33%28%74%68%69%73%29%22%20%6F%6E%46%6F%63%75%73%3D%22%6A%61%76%61%73%63%72%69%70%74%3A%73%65%62%5F%74%72%61%6E%73%70%6F%73%65%32%31%32%33%28%74%68%69%73%29%22%3E%43%6F%6E%74%61%63%74%20%55%73%3C%2F%61%3E%27%29%3B'));</script><noscript>ask-epd [AT] googlegroups.com</noscript></address>
<font size="2">
<blockquote>This manual and the database it accompanies may be copied
and
redistributed freely, without advance permission, provided that this
statement
is reproduced with each copy.
  <p>Published Research assisted by the Eukaryotic Promoter Database
should
cite: <br>
EPD in its twentieth year: towards complete promoter coverage of
selected model organisms<br>
Schmid, C.D., Perier, R., Praz, V. and Bucher, P. (2006) Nucleic Acids
Res, <span style="font-weight: bold;">34</span>, D82-85.</p>
</blockquote>
</div>
<hr>
<div class="TOC">
<center>
<h2>EPD RELEASE 128, July 2016</h2>
</center>
<b><font color="#ff0000">WHAT IS NEW IN RELEASE 128:</font></b>
Update to new EMBL Release
<br>
&nbsp;
<a href="/current/EPD_release_history.html">EPD
release history</a>
<!--SECTION--><!--CONTENTS-->
<h2 class="section">CONTENTS</h2>
<ol>
  <li> <a href="#INTRODUCTION">INTRODUCTION</a></li>
  <li> <a href="#PROMOTER_SELECTION">PROMOTER SELECTION</a></li>
  <li> <a href="#ASSIGNMENT_OF_TRANSCRIPTION_INITIATION_SITE">ASSIGNMENT
OF INITIATION
SITE</a></li>
  <li> <a href="#FORMAT_CONVENTIONS">FORMAT CONVENTIONS</a></li>
  <ol>
    <li> <a href="#The_title_line">The title line</a></li>
    <li> <a href="#Promoter_entries">Promoter entries</a></li>
    <ol>
      <li> <a href="#The_ID_line">The ID line</a></li>
      <li> <a href="#The_AC_line">The AC line</a></li>
      <li> <a href="#The_DT_line">The DT line</a></li>
      <li> <a href="#The_DE_line">The DE line</a></li>
      <li> <a href="#The_OS_line">The OS line</a></li>
      <li> <a href="#The_HG_line">The HG line</a></li>
      <li> <a href="#The_AP_line">The AP line</a></li>
      <li> <a href="#The_NP_line">The NP line</a></li>
      <li> <a href="#The_DR_line">The DR line</a></li>
      <li> <a href="#The_RN,_RX,_RA,_RT_and_RL_lines">The RN, RX, RA,
RT
and RL lines</a></li>
      <li> <a href="#The_ME_line">The ME line</a></li>
      <li> <a href="#The_SE_line">The SE line</a></li>
      <li> <a href="#The_FL_line">The FL line</a></li>
      <li> <a href="#The_IF_line">The IF line</a></li>
      <li> <a href="#The_TX_line">The TX line</a></li>
      <li> <a href="#The_KW_line">The KW line</a></li>
      <li> <a href="#The_FP,_DO_and_RF_lines">The FP, DO and RF lines</a></li>
      <li> <a href="#The_//_line">The // line</a></li>
    </ol>
    <li> <a href="#Line_types_retained_from_the_old_format">Line types
retained
from the old format</a></li>
    <ol>
      <li> <a href="#The_FP_line">The FP line</a></li>
      <li> <a href="#Documentation">Documentation</a></li>
      <li> <a href="#Literature_references">Literature references</a></li>
      <li> <a href="#Miscellaneous">Miscellaneous</a></li>
    </ol>
    <li> <a
 href="#Distinct_format_of_preliminary_entries_in_epd_bulk.dat">Distinct
format of 'preliminary' entries in epd_bulk.dat</a></li>
  </ol>
  <li> <a href="#CLASSIFICATION">CLASSIFICATION</a></li>
  <li> <a href="#HOMOLOGOUS_PROMOTERS">HOMOLOGOUS PROMOTERS</a></li>
  <li> <a href="#PROMOTER_SEQUENCE_RETRIEVAL">PROMOTER SEQUENCE
RETRIEVAL</a></li>
  <li> <a href="#REFERENCES">REFERENCES</a></li>
</ol>
<ol type="A">
  <li> <a href="/current/SURVEY.html">APPENDIX
A
: SURVEY
OF RELEASE</a></li>
  <li> <a href="#APPENDIXB">APPENDIX B&nbsp; : CODES AND ABBREVIATIONS</a></li>
  <ol>
    <li> <a href="#SPECIES_CODES">SPECIES CODES</a></li>
    <li> <a href="#JOURNAL_CODES">JOURNAL CODES</a></li>
    <li> <a href="#ABBREVIATIONS">ABBREVIATIONS</a></li>
  </ol>
</ol>
</div>
<!--SECTION-->
<!--INTRO--><a name="INTRODUCTION"></a>
<h2 class="section">1 INTRODUCTION</h2>
The Eukaryotic Promoter Database EPD was designed and developed at the
Weizmann Institute of Science in Rehovot (Israel) and is currently
maintained
at ISREC in Epalinges s/Lausanne (Switzerland). EPD is a specialized
annotation
database of the EMBL Data Library. It provides information about
eukaryotic
promoters available in the EMBL Data Library and is intended to assist
experimental researchers, as well as computer analysts, in the
investigation
of eukaryotic transcription signals. The present version originated
from
a previous compilation published in an article (<a
 href="/current/usrman.html#ref_1">1</a>)
and is organized as a hierarchically ordered and documented "functional
position set" (<a
 href="/current/usrman.html#ref_2">2</a>)
pointing to transcription initiation sites. All information is either
directly
extracted from scientific literature or, starting from release 73,
compiled
by a new&nbsp;<span style="font-style: italic;">in silico</span> primer
extension method (<a href="#ref_16">16</a>). Thus promoter information
in EPD is independent of the EMBL sequence entry descriptions. As a
consequence,
many of the initiation sites referred to in EPD do not appear in
corresponding
EMBL feature tables.A coordinated updating procedure has been set up by
the two laboratories that will ensure future compatibility between the
position references in EPD and the sequence data in the main data
library.
Investigators who access EMBL via publicly available programs should be
aware of the fact that software producers occasionally modify the
sequence
data in ways that render position references inaccurate. EPD is
generally
not compatible with sequence data of another release because EMBL
sequence
entries are not designed as stable data units. The completeness and
accuracy
of EPD greatly benefits from user-feedback. Any report of mistakes or
omissions
would be very much appreciated. Direct communication of newly published
transcript mapping or gene expression data is also welcome. Please
forward
all correspondence to the address given on top of this document. Use
electronic
mail if possible.
<!--SECTION--><!--PROMOTER--><br>
<a name="PROMOTER_SELECTION"></a>
<h2 class="section">2 PROMOTER SELECTION</h2>
EPD is a rigorously selected database. In order to be included in EPD,
a promoter must be:
<ol>
  <li>recognized by eukaryotic RNA POL II,</li>
  <li>active in a higher eukaryote,</li>
  <li>experimentally defined, or homologous and sufficiently similar to
an
experimentally
defined promoter,</li>
  <li>biologically functional,</li>
  <li>available in the current EMBL release,</li>
  <li>distinct from other promoters in the database.</li>
</ol>
Explanations:
<ol>
  <li>Transcription by RNA POL II is bona fide assumed for protein
coding
genes
but must be supported by alpha-amanitin data if the end product is an
RNA.</li>
  <li>All eukaryotes except phycophyta, fungi, myxomycetes, and
protozoa are
considered higher eukaryotes. Note that the expression "active in" does
not always refer to the source organism of the promoter (e.g. in
viruses).
EPD contains currently promoter sequences from 139 different <a
 href="#SPECIES_CODES">species</a>.</li>
  <li>A promoter is experimentally determined if a corresponding
transcription
initiation site is mapped with a precision of +/- 5 bp or higher. Any
technique
that characterizes the 5'terminus of an in vivo or in vitro generated
RNA
is acceptable. Single nuclease-protection or primer-extension data must
be accompanied by additional evidence unless the gene's intron-exon
organization
is well established. Similarity is considered "sufficient" if percent
identity
(as defined in Section 6) is &gt;=60% between -79 and +20 or &gt;=75%
between
-49 and +10.</li>
  <li>A promoter is biologically functional if it contributes to the
source
organism's
survival and/or reproduction. This is bona fide assumed except for
promoters
of pseudogenes, minor transcription initiation sites (&lt;20% of total
gene transcripts), promoters giving rise to an unstable RNA product,
and
mutant promoter.</li>
  <li>The minimum sequence requirement is 45 bp between -49 and +10.</li>
  <li>Promoters are considered distinct if they originate from
different gene
loci or different species. Identity is assumed if two promoters from
the
same species exhibit &gt;95% similarity between -79 and +20 while their
genetic
relationship is unknown. Multiple isolates of viruses or transposable
elements
are considered distinct if at least one promoter region fails to
fulfill
the above similarity criterion.</li>
</ol>
<!--SECTION-->
<!--TSS_assignment--><a
 name="ASSIGNMENT_OF_TRANSCRIPTION_INITIATION_SITE"></a>
<h2 class="section">3 ASSIGNMENT OF TRANSCRIPTION INITIATION SITE</h2>
A eukaryotic promoter is defined as a DNA sequence around a
transcription
initiation site. The position reference to the initiation site is
therefore
the central part of a promoter entry. Its assignment is based directly
on experimental data shown in an article, proposed adjustments
originating
from consensus sequence considerations being ignored.
<font color="#000000">In
the case of minor discrepancies between different publications averaged
</font>positions
are given. Position references are subject to permanent re-evaluation.
A transcription initiation site may be reassigned upon publication of
new
data. Position references are replaced if longer upstream sequences of
the same promoter become available in a new EMBL sequence entry.
<br>
Several initiation sites preceding the same gene appear as alternative
promoters if they are clearly separated from each other or
differentially
regulated. The minimum distance required between two alternative
initiation
sites is 20 bp. Otherwise, they are considered a single promoter
region.
<br>
Four types of promoters are distinguished by one-letter codes in order
to account for the variety of transcription initiation patterns in
eukaryotes:
<ul>
  <li>S: Single initiation site: &gt;90% of all reported transcripts
initiate
within
10 bp (the experimental data usually do not allow distinction between a
single cap-site and small mRNA 5' heterogeneity).</li>
  <li>M: Multiple initiation sites: &gt;75% of all reported transcripts
initiate
within 20 bp.</li>
  <li> <font color="#000000">R: Initiation region: &gt;75% of all
reported
transcripts
initiate within 100 bp.</font></li>
  <li> <font color="#000000">U: Undefined transcription initiation
pattern, exclusively
in 'preliminary' entries in epd_bulk.dat (see next section).</font></li>
</ul>
<font color="#000000">Note that in addition to true alternative
promoter
activity, variability in the position of the transcription initiation
site
might also be due to experimental constraints, a biological variability
in the activity of the DNA polymerase II, or the presence of highly
similar
(pseudo-) genes with distinct transcription initiation sites.</font>
<br>
<font color="#000000">In sequence entries that contain a c</font>omplete
RNA or DNA genome of a retrovirus or a retrovirus-like transposable
elements,
the position reference points to the U3/R boundary of the 3'terminal
LTR.
<br>
<!--SECTION-->
<!--FORMAT--><a name="FORMAT_CONVENTIONS"></a>
<h2 class="section">4 FORMAT CONVENTIONS</h2>
EPD is distributed as two ASCII flatfiles (epd.dat, epd_bulk.dat) in
essentially
identical format. Differences in the format of 'preliminary' entries in
'epd_bulk.dat' are described in <a
 href="#Distinct_format_of_preliminary_entries_in_epd_bulk.dat">paragraph
4.4</a>. EPD files contain a title line followed by a number of
promoter
entries. Interspersed are group headings whose function and format are
described in the next section. The title line and parts of the promoter
entries are rigidly formatted so that the entire database conforms to
the
standards of an FPS file (functional position set) of our current
signal
search analysis (<a
 href="/current/usrman.html#ref_1">1</a>,<a
 href="/current/usrman.html#ref_2">2</a>)
software.
<!--SECTION--><br>
<a name="The_title_line"></a>
<h3 class="subsection">4.1. The title line</h3>
The title line of EPD is shown below:
<pre>TI&nbsp;&nbsp; EPD83&nbsp;&nbsp;&nbsp;&nbsp; Eukaryotic Promoter Database / Release 83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; EP</pre>
The TI line contains the following fields:
<center><br>
<table>
  <caption>&nbsp;
  <center>
  <p></p>
  </center>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <th>columns</th>
      <th>data type</th>
    </tr>
    <tr>
      <td>1- 2</td>
      <td>"TI"</td>
    </tr>
    <tr>
      <td>3- 5</td>
      <td>(blank)</td>
    </tr>
    <tr>
      <td>6-15</td>
      <td>FPS name</td>
    </tr>
    <tr>
      <td>16-70</td>
      <td>title</td>
    </tr>
    <tr>
      <td>71-72</td>
      <td>FPS code</td>
    </tr>
  </tbody>
</table>
</center>
Explanations:
<ul>
  <li>FPS name and FPS code are used by our data extraction software to
generate
default names for output files.</li>
</ul>
<p><br>
<a name="Promoter_entries"></a></p>
<h3 class="subsection">4.2. Promoter entries</h3>
An EPD entry contains the following types of information:
<ul>
  <li>Promoter identification and description.</li>
  <li>Machine-readable pointers to the transcription initiation site in
corresponding
sequence entries.</li>
  <li>Description of the experimental evidence defining the
transcription
start
site.</li>
  <li>Various kinds of promoter classifications useful for extraction
of
biologically
meaningful promoter subsets.</li>
  <li>Information on regulatory properties.</li>
  <li>Cross-references to other databases.</li>
  <li>Bibliographic references.</li>
</ul>
Promoter entries are presented in a similar format as EMBL and
SWISS-PROT
sequence entries. Each line starts with a line code identifying the
type
of information presented. The current line types and line codes and the
order in which they appear in an entry, are shown below:
<pre>&nbsp;&nbsp;&nbsp; ID&nbsp; - IDentification.<br>&nbsp;&nbsp;&nbsp; AC&nbsp; - ACcession number(s).<br>&nbsp;&nbsp;&nbsp; DT&nbsp; - DaTe.<br>&nbsp;&nbsp;&nbsp; DE&nbsp; - DEscription.<br>&nbsp;&nbsp;&nbsp; OS&nbsp; - Organism Species.<br>&nbsp;&nbsp;&nbsp; HG&nbsp; - Homology Group.<br>&nbsp;&nbsp;&nbsp; AP&nbsp; - Alternative Promoter.<br>&nbsp;&nbsp;&nbsp; NP&nbsp; - Neighbouring Promoter.<br>&nbsp;&nbsp;&nbsp; DR&nbsp; - Database cross-References.<br>&nbsp;&nbsp;&nbsp; RN&nbsp; - Reference Number.<br>&nbsp;&nbsp;&nbsp; RX&nbsp; - Reference cross-references.<br>&nbsp;&nbsp;&nbsp; RA&nbsp; - Reference Authors.<br>&nbsp;&nbsp;&nbsp; RT&nbsp; - Reference Title.<br>&nbsp;&nbsp;&nbsp; RL&nbsp; - Reference Location.<br>&nbsp;&nbsp;&nbsp; ME&nbsp; - MEthods.<br>&nbsp;&nbsp;&nbsp; SE&nbsp; - SEquence.<br>&nbsp;&nbsp;&nbsp; FL&nbsp; - Full Length.<br>&nbsp;&nbsp;&nbsp; IF&nbsp; - Initiation Frequency.<br>&nbsp;&nbsp;&nbsp; TX&nbsp; - TaXonomy.<br>&nbsp;&nbsp;&nbsp; KW&nbsp; - KeyWords.<br>&nbsp;&nbsp;&nbsp; FP&nbsp; - Functional Position.<br>&nbsp;&nbsp;&nbsp; DO&nbsp; - DOcumentation.<br>&nbsp;&nbsp;&nbsp; RF&nbsp; - literature ReFerence.<br>&nbsp;&nbsp;&nbsp; //&nbsp; - Termination line.</pre>
Spacer lines (XX) are inserted in order to make the promoter database
easier
to read by eye. Some line types occur many times in a single entry.
Each
entry must begin with an identification line (ID) and end with a
terminator
line (//). Text does not exceed column 72. Below is an example of a
promoter
entry:
<pre>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ID&nbsp;&nbsp; HS_MYC_2&nbsp;&nbsp;&nbsp;&nbsp; standard; single; VRT.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AC&nbsp;&nbsp; EP11148;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DT&nbsp;&nbsp; ??-APR-1987 (Rel. 11, created)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DT   07-MAR-2005 (Rel. 82, Last annotation update).<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DE&nbsp;&nbsp; c-myc (cellular homologue of myelocytomatosis virus 29 oncogene),<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DE&nbsp;&nbsp; promoter 2.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OS&nbsp;&nbsp; Homo sapiens (human)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HG&nbsp;&nbsp; Homology group 53; Mammalian c-myc proto-oncogene, promoter 2<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AP&nbsp;&nbsp; Alternative promoter #2 of 2; exon 1; site 2; major promoter.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NP&nbsp;&nbsp; none.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   GENOME; NT_008046.15; NT_008046; [-41966656, 15188617].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EPD; EP11146; HS_MYC_1; alternative promoter; [-162; +].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   CLEANEX; HS_MYC.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; AC103819.3; [-87815, 60206].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; X00364.2; [-2489, 8507].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; D10493.1; [-2487, 5569].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K01910.1; [-2451, 49].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; M16261.1; [-1843, 1048].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; J03253.1; [-1759, 461].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; L00057.1; [-810, 2795].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K03015.1; [-555, 458].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; X00196.1; [-532, 2792].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; M12026.1; [-511, 678].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K01708.1; [-410, 500].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K00559.1; [-345, 1020].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K02280.1; [-302, 178].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K01909.1; [-266, 1365].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; S65124.1; [-266, 1023].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; M14206.1; [-266, 446].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; M20013.1; [-240, 982].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; AF111270.1; [-142, 264].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K02275.1; [-96, 780].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; X00675.1; [-96, 404].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   EMBL; K02277.1; [-96, 157].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   SWISS-PROT; P01106; MYC_HUMAN.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R01157; HS$CMYC_01; [-211, -189]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R01158; HS$CMYC_02; [-168, -145]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R01804; HS$CMYC_04; [-300, -283]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R01851; HS$CMYC_05; [-65, -57]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R01852; HS$CMYC_06; [-42, -34]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R04076; HS$CMYC_12; [-251, -228]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R04076; HS$CMYC_12; [-252, -229]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R04076; HS$CMYC_12; [-253, -230]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R04621; HS$CMYC_17; [-313, -262]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R08503; HS$CMYC_18; [-50, -41]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R16688; HS$CMYC_24; [-7, 41]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R16689; HS$CMYC_25; [-7, 41]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R17051; HS$CMYC_30; [-510, -480]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R18503; HS$CMYC_31; [-185, -170]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   TRANSFAC; R18504; HS$CMYC_32; [-153, -168]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   RefSeq; NM_002467.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DR   MIM; 190080.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RN&nbsp;&nbsp; [1]<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RX&nbsp;&nbsp; MEDLINE; 84026482.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RA&nbsp;&nbsp; Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H.,<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RA&nbsp;&nbsp; Lenoir G., Leder P.;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; "The human c-myc oncogene: structural consequences of<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; translocation into the IgH locus in Burkitt lymphoma";<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RL&nbsp;&nbsp; Cell 34:779-787(1983).<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RN&nbsp;&nbsp; [2]<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RX&nbsp;&nbsp; MEDLINE; 84131953.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RA&nbsp;&nbsp; Bernard O.D., Cory S., Gerondakis S., Webb E., Adams J.M.;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; "Sequence of the murine and human cellular myc oncogenes and two<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; modes of myc transcription resulting from chromosome translocation<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; in B lymphoid tumours";<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RL&nbsp;&nbsp; EMBO J. 2:2375-2383(1983).<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RN&nbsp;&nbsp; [3]<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RX&nbsp;&nbsp; MEDLINE; 87257828.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RA&nbsp;&nbsp; Lipp M., Schilling R., Wiest S., Laux G., Bornkamm G.W.;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; "Target sequences for cis-acting regulation within the dual<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; promoter of the human c-myc gene.";<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RL&nbsp;&nbsp; Mol. Cell. Biol. 7:1393-1400(1987).<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RN&nbsp;&nbsp; [4]<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RX&nbsp;&nbsp; MEDLINE; 88038843.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RA&nbsp;&nbsp; Broome H.E., Reed J.C., Godillot E.P., Hoover R.G.;<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; "Differential promoter utilization by the c-myc gene in mitogen-<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RT&nbsp;&nbsp; and interleukin-2-stimulated human lymphocytes.";<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RL&nbsp;&nbsp; Mol. Cell. Biol. 7:2988-2993(1987).<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ME&nbsp;&nbsp; Nuclease protection [1,4].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ME&nbsp;&nbsp; Nuclease protection; transfected or transformed cells [3].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ME&nbsp;&nbsp; Length measurement of an RNA product; low-precision data [1].<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SE&nbsp;&nbsp; agggagggatcgcgctgagtataaaagccggttttcggggctttatctaACTCGCTGTAG<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TX&nbsp;&nbsp; 6. Vertebrate promoters<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TX&nbsp;&nbsp; 6.1. Chromosomal genes<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TX&nbsp;&nbsp; 6.1.5. Hormones, growth factors, regulatory proteins<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TX&nbsp;&nbsp; 6.1.5.16. Various cellular protooncogenes<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; KW&nbsp;&nbsp; Proto-oncogene, Nuclear protein, DNA-binding, Glycoprotein,<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; KW&nbsp;&nbsp; Transcription regulation.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>      FP   Hs c-myc         P2+:+S  EU:NC_000008.9       1+ 128817660; 11148.053 010*2<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; XX<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Experimental evidence: 4,4#,2l<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Expression/Regulation: +mitogen<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; RF&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell34:779&nbsp;&nbsp;&nbsp;&nbsp; EMBOJ2:2375&nbsp;&nbsp;&nbsp; MCB7:1393&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MCB7:2988<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; //</pre>
A detailed description of each line type is given below.
<br>
<!--SECTION-->
<!--ID--><a name="The_ID_line"></a>
<h4 class="subsubsection">4.2.1. The ID line</h4>
The identification line is always the first line of an entry. The
general
form of the ID line is:
<pre>ID&nbsp;&nbsp; ENTRY_NAME data class; initiation site type; TAXONOMIC DIVISION.</pre>
<ul>
  <li> <i>ENTRY_NAME</i> is a unique entry identifier "<tt>HS_MYC_2</tt>"
which
obeys rigorous naming conventions. It contains 2 or 3 fields, the first
is the species identification code at most 4 alphanumeric characters
representing
the biological source of the promoter. The second field uses for gene
identification
the protein code of SWISS-PROT ID (if available). For human EPD
entries,
instead of the SwissProt ID the official gene symbol approved by the <a
 href="https://www.genenames.org/">HUGO
nomenclature committee</a> (if available) is used. The third field is
optional,
it is either a number which represents alternative promoters or a
letter
for promoters of duplicated genes. The `_' sign serves as a separator.</li>
  <li>The <i>data class</i> field relates to the quality of the
information:
"standard" means that the information is complete and correct according
the standards laid down in this document; "preliminary" means that the
entry has not yet undergone all quality checks necessary for being
classified
as "standard".</li>
  <li>The <i>initiation site type</i> is either "single", "multiple",
"region"
as defined in <a
 href="/current/usrman.html#ASSIGNMENT_OF_TRANSCRIPTION_INITIATION_SITE">Section
3</a>.</li>
  <li> <i>TAXONOMIC DIVISION</i> are</li>
  <ul>
    <li>PLN for plant</li>
    <li>NEM for nematode</li>
    <li>ART for arthropode</li>
    <li>MLS for mollusc</li>
    <li>ECH for echinoderm</li>
    <li>VRT for vertebrates.</li>
  </ul>
Note that these codes relate to the organism in which the promoter is
expressed,
not to the source organism in which the promoter is replicated as
defined
on the OS line.
</ul>
The ID line is terminated by a period.
<br>
<!--SECTION-->
<!--AC--><a name="The_AC_line"></a>
<h4 class="subsubsection">4.2.2. The AC line</h4>
<pre>AC&nbsp;&nbsp; EP11148;</pre>
The accession number consists of the character string "<tt>EP</tt>"
followed
by 5 digits representing the EMBL release number followed by the EPD
entry
order. Most EPD entries currently have only one accession number. If
necessary,
more then one AC will be used, separated by semicolons and the list is
terminated by a semicolon.
<br>
<!--SECTION-->
<!--DT--><a name="The_DT_line"></a>
<h4 class="subsubsection">4.2.3. The DT line</h4>
The date lines show the date of entry or last modification of the
entry.
<pre>DT&nbsp;&nbsp; DD-MMM-YEAR (Rel. XX, Comment)</pre>
where `DD' is the day, `MMM' the month, `YEAR' the year, and `XX' the
EPD
release number. The comment portion of the line indicates the action
taken
on that date.
<ul>
  <li>The first DT line indicates when the entry first appeared in the
database.</li>
  <li>The second DT line indicates when the promoter data was last
modified.
It is terminated by a period.</li>
</ul>
<!--SECTION-->
<!--SECTION--><!--SECTION--><!--DE--><a name="The_DE_line"></a>
<h4 class="subsubsection">4.2.4. The DE line</h4>
<pre>DE&nbsp;&nbsp; c-myc (cellular homologue of myelocytomatosis virus 29 oncogene),<br>DE&nbsp;&nbsp; promoter 2.</pre>
The description lines contain general descriptive information about the
promoter. The description is given in ordinary English and is
free-format.
It contains the swiss-prot gene names when known. In some cases, more
than
one DE line is required; in this case, the text is divided only between
words. The last DE line is terminated by a period.<br>
<!--SECTION-->
<!--OS--><a name="The_OS_line"></a>
<h4 class="subsubsection">4.2.5. The OS line</h4>
<pre>OS&nbsp;&nbsp; Mus musculus (house mouse)</pre>
The species line specifies the source organism(s) of the promotery. The
species names are based on NCBI's taxonomy and thus can be
automatically
hyperlinked to the NCBI's taxonomy web pages.<br>
<!--SECTION-->
<!--HG--><a name="The_HG_line"></a>
<h4 class="subsubsection">4.2.6. The HG line</h4>
<pre>HG&nbsp;&nbsp; Homology group 53; Mammalian c-myc proto-oncogene, promoter 2</pre>
The <a href="/current/HG.html">homology group</a>
line is optional, it contains 2 fields: a homology group number that
allows
identification of all sequence-wise similar promoters in EPD, and a
homology
group name.<br>
<!--SECTION-->
<!--AP--><a name="The_AP_line"></a>
<h4 class="subsubsection">4.2.7. The AP line</h4>
<pre>AP&nbsp;&nbsp; Alternative promoter #2 of 2;<font color="#000000"> 5' e</font>xon 1; site 2; major promoter.</pre>
The AP line is optional and provides information on <a
 href="/current/AP.html">alternative
promoters</a> of the same gene (for more details, see Section 4.3.1.).
It contains 3 or 4 fields, separated by semicolons, providing the
following
types of information:
<ul>
  <font color="#000000">descriptive text fields followed by</font>
</ul>
<ul>
  <li>Two numbers indicating, respectively, the promoter's relative
position
along the gene, and the total number of alternative promoters of the
gene.
Promoters are numbered in the 5' to 3' directions starting with one.</li>
  <li>A number referring to the exon preceded by the promoters. Note
that
multiple
promoters may be associated with the same (3'-coterminal) exon or with
different exons. Known exons are numbered in 5' to 3' direction
starting
with one.</li>
  <br>
  <font color="#000000">Note that the nomenclature of 5'-exons in EPD
may differ from the usage in the literature.</font> <li>A number
indicating the promoter's relative position among the
subset of
promoters preceeding the same exon.</li>
  <li>An optional keyword indicating major promoters.</li>
</ul>
The AP line is terminated by a period.<br>
<!--SECTION-->
<!--NP--><a name="The_NP_line"></a>
<h4 class="subsubsection">4.2.8. The NP line</h4>
<pre>NP&nbsp;&nbsp; Neighbouring Promoter; EP23008; MM_H2B1; [-209; -].</pre>
The NP line is optional and provides information on promoters which are
physically closer to each other than 1000 bp. It contains 3 fields,
separated
by semicolons, providing the following types of information:
<ul>
  <li>The EPD accession number of the neighbouring promoter.</li>
  <li>The EPD identifier of the neighbouring promoter.</li>
  <li>The last field indicates, respectively, the position and the
direction
of the neighbouring promoter relative to the transcription initiation
site
given in the promoter entry.</li>
  <ul>
    <li>Negative numbers indicate the upstream region of this entry and
positive
ones indicate the downstream region.</li>
    <li>The sign indicates the transcription direction of the
neighbouring
promoter
relative to the promoter entry:</li>
    <br>
"+" means same direction <br>
"-" means opposite direction
  </ul> </ul> <!--SECTION--> <!--DR--> <a name="The_DR_line"></a> <h4
class="subsubsection">4.2.9. The DR line</h4> The DR lines contain
cross-references to other EPD entries (if there are alternative
promoters of the same gene), or to entries from other databases.  So
far, we have incorporated links to <a
href="http://cleanex.vital-it.ch/current/CleanEx_manual.html">CLEANEX</a>, EMBL
(<a href="/current/usrman.html#ref_3">3</a>),
GenBank (<a
href="/current/usrman.html#ref_4">4</a>), DDBJ
(<a
href="/current/usrman.html#ref_5">5</a>),&nbsp;
SWISS-PROT (<a
href="/current/usrman.html#ref_6">6</a>),
TRANSFAC (<a
href="/current/usrman.html#ref_7">7</a>),&nbsp;
Flybase (<a
href="/current/usrman.html#ref_8">8</a>), MIM
(<a href="/current/usrman.html#ref_9">9</a>) and
MGD (<a
href="/current/usrman.html#ref_10">10</a>).  The
precise format of these lines depends on the target database. Note
that some cross-references include numbers enclosed in square brackets
indicating the relative position of a linked sequence object, or
keywords characterising the nature of the relationship between the
entries. For instance, the ranges associated with cross-references to
EMBL entries define the extensions of the EMBL sequences relative to
the initiation site described by the EPD entry. The multiplicity of
EMBL cross-references in some entries mirrors the redundancy of the
sequence database. The first of these references corresponds to the
longest promoter region, except when the sequences are cancelled from
EMBL database, but still exist in GenBank or DDBJ.  <br> The format of
the DR line is shown by the following example <font
 color="#000000">lines:</font>
<pre><font color="#000000">&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; GENOME; NT_037436.1; NT_037436; [-14139754, 9212459].<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; EPD; EP11146; HS_MYC_1; alternative promoter; [-162; +].<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; EMBL; J00120.1; [-2489, 8507].<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; SWISS-PROT; P01106; MYC_HUMAN.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; SPTREMBL; Q8IQL1.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; FLYBASE; FBgn0013718; nuf.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; TRANSFAC; R01804; HS$CMYC_04; [-300, -283]; by position.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; MIM; 190080.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; RefSeq; NM_003529.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; MGD; MGI:88468; Cola2.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; ENSEMBL; CG32140.<br>&nbsp;&nbsp;&nbsp;&nbsp; DR&nbsp;&nbsp; TRANSCRIPTOME; DMe000571.</font></pre>
Explanations (for detailed information go to <a
 href="/current/guidelines.html">Guidelines
</a>):
<ul>
  <li> The first item on the DR line is the
abbreviated
name of the data collection to which reference is made. The currently
defined
data bank identifiers are the following:</li>
  <br>
  <table>
    <caption>&nbsp; <br>
    </caption><tbody>
    </tbody><tbody>
    </tbody><tbody>
    </tbody> <tbody>
      <tr>
        <td><font color="#000000">GENOME</font></td>
        <td><font color="#000000">NCBI Reference Sequence (RefSeq) of
genomic sequence
contigs</font></td>
      </tr>
      <tr>
        <td><font color="#000000">EPD</font></td>
        <td><font color="#000000">Eukaryotic Promoter Database:
alternative promoters
of the same gene</font></td>
      </tr>
      <tr>
        <td><font color="#000000">CLEANEX</font></td>
        <td><font color="#000000">Gene expression database for human
EPD promoters</font></td>
      </tr>
      <tr>
        <td><font color="#000000">EMBL</font></td>
        <td><font color="#000000">Nucleotide sequence database of the
EMBL</font></td>
      </tr>
      <tr>
        <td><font color="#000000">SWISS_PROT</font></td>
        <td><font color="#000000">Protein sequence database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">SPTREMBL</font></td>
        <td><font color="#000000">Subset of protein sequence database
TrEMBL. It
contains the entries which should be eventually incorporated into
SWISS-PROT.
SWISS-PROT accession numbers have been assigned for all SP-TrEMBL
entries</font></td>
      </tr>
      <tr>
        <td><font color="#000000">FLYBASE</font></td>
        <td><font color="#000000">Drosophila genome database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">TRANSFAC</font></td>
        <td><font color="#000000">Transcription factor (TF) database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">MIM</font></td>
        <td><font color="#000000">Mendelian Inheritance in Man Database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">RefSeq</font></td>
        <td><font color="#000000">Reference Sequence Database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">MGD</font></td>
        <td><font color="#000000">Mouse Genome Database</font></td>
      </tr>
      <tr>
        <td><font color="#000000">ENSEMBL</font></td>
        <td><font color="#000000">Metazoan genome annotation</font></td>
      </tr>
      <tr>
        <td><font color="#000000">TRANSCRIPTOME</font></td>
        <td><font color="#000000">Catalog of transcripts and their
mapping onto
the genome (LICR Lausanne branch)&nbsp;</font></td>
      </tr>
      <tr>
        <td><font color="#000000">TIGR</font></td>
        <td><font color="#000000">'gene identifiers' from the 'Rice
Genome Annotation'
project at TIGR</font></td>
      </tr>
    </tbody>
  </table>
  <li>The second item is the primary accession number (or an equivalent
unique
identifier of another data banks) of the entry to which reference is
made.</li>
  <li>The third item (if it exists) is a secondary idientifier or name
for
the
cross-referenced database entry.</li>
  <li>The fourth item for EMBL and Transfac indicates the location and
extension
of the sequences given in these entries relative to the transcription
initiation
site given in the promoter entry. Negative numbers indicate the
upstream
region of this site and positive ones indicate the downstream part.</li>
  <li>The fifth item</li>
  <ul>
    <li>in the EPD line, indicates the position and the direction of
the
alternative
promoter as it is defined for the neighbouring promoter in the <a
 href="/current/usrman.html#The_NP_line">NP</a>
line last field</li>
    <li>in the TRANSFAC line, designates the criteria used to collect
the TF
entry:</li>
    <br>
- by position: The TF binding site is situated between -500 and + 100,
+1 being the transcription initiation site <br>
- by function: The TF binding site is known to regulate the
corresponding
promoter.
  </ul>
</ul>
<i>NB </i>: TRANSFAC cross-reference lines should not exceed the real
number
of binding sites found in "TRANSFAC Site Table". Thus the position
given
in this DR line in related to the longest EMBL entry common to both EPD
and TRANSFAC (version 6.3) databases.<br>
<!--SECTION-->
<!--RA--><a name="The_RN,_RX,_RA,_RT_and_RL_lines"></a>
<h4 class="subsubsection">4.2.10. The RN, RX, RA, RT and RL lines</h4>
These lines comprise the literature citations within EPD. The citations
indicate the papers from which the data has been abstracted. The
reference
lines for a given citation occur in a block, and are always in the
order
RN, RX, RA, RT, RL. Within each such reference block the RN line occurs
once, the RX lines occurs zero or more times, and the RA, RT and RL
lines
each occur one or more times. If several references are given, there
will
be a reference block for each.An example of a complete reference is:
<pre>RN&nbsp;&nbsp; [1]<br>RX&nbsp;&nbsp; MEDLINE; 84026482.<br>RA&nbsp;&nbsp; Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H.,<br>RA&nbsp;&nbsp; Lenoir G., Leder P.;<br>RT&nbsp;&nbsp; "The human c-myc oncogene: structural consequences of<br>RT&nbsp;&nbsp; translocation into the IgH locus in Burkitt lymphoma";<br>RL&nbsp;&nbsp; Cell 34:779-787(1983).</pre>
The formats of the individual lines are explained below. &gt;<a
 name="The_RN_line"></a>
<h4 class="subsubsubsection">4.2.10.1. The RN line</h4>
The RN line gives a sequential number to each reference citation in an
entry.This number is used to indicate the reference in the ME lines.<a
 name="The RX line"></a>
<h4 class="subsubsubsection">4.2.10.2 The RX line</h4>
The RX line is an optional line which is used to indicate the
identifier
assigned to a specific reference in PubMed (PMID, from the National
Library
of Medicine (NLM)). .<a name="The_RA_line"></a>
<h4 class="subsubsubsection">4.2.10.3 The RA line</h4>
The RA lines list the authors of the paper (or other work) cited. The
authors
are are listed in the order given in the paper. The names are listed
surname
first followed by a blank followed by initial(s) with periods. The
authors'
names are separated by commas and terminated by a semicolon. Author
names
are not split between lines.&nbsp;<a name="The_RT_line"></a>
<h4 class="subsubsubsection">4.2.10.4 The RT line</h4>
The RT lines contain the title of the reference citation.<a
 name="The RL line"></a>
<h4 class="subsubsubsection">4.2.10.5 The RL line</h4>
The RL lines contain the conventional citation information for the
reference.
In general, the RL lines alone are sufficient to find the paper in
question.
It includes the journal abbreviation, the volume number, the page
range,
and the year. Journal names are abbreviated according to the
conventions
used by the National Library of Medicine (NLM) and are based on the
existing
ISO and ANSI standards.<br>
<!--SECTION-->
<!--ME--><a name="The_ME_line"></a>
<h4 class="subsubsection">4.2.11. The ME line</h4>
The method lines describe experiments defining the transcription
initiation
site. The format of the ME line is as follows:
<pre>ME&nbsp;&nbsp; Method_description [; Qualifier...] [n,...].</pre>
A complete list of method descriptions is given in Section 4.3.2.
Qualifiers
may indicate that an experimental gene transcription system was used,
that
data are of low precision (less +/- 5 bp), or that the experiments were
done with a closely related gene. The number(s) enclosed in square
brackets
links the method descriptions to the bibliographic references included
in the promoter entry. The methods line from the example are:
<pre>ME&nbsp;&nbsp; Nuclease protection [1,4].<br>ME&nbsp;&nbsp; Nuclease protection; transfected or transformed cells [3].<br>ME&nbsp;&nbsp; Length measurement of an RNA product; low-precision data [1].</pre>
<!--SECTION-->
<!--SE--><a name="The_SE_line"></a>
<h4 class="subsubsection">4.2.12. The SE line</h4>
The sequence line shows a short sequence segment corresponding to the
-49
to +10 region of the promoter. Transcribed and untranscribed
nucleotides
are represented by upper and lower case characters, respectively. This
line type is not meant to provide sequence data but serves as a control
string for sequence extraction.<br>
<!--SECTION-->
<!--FL--><a name="The_FL_line"></a>
<h4 class="subsubsection">4.2.13. The FL line</h4>
<div class="subsubsection">The Full length line designates the
large-scale
cDNA sequencing projects : NEDO (<a
 href="/current/usrman.html#ref_11">11</a>),
MGC (<a href="/current/usrman.html#ref_12">12</a>),
<font color="#993399">and
BDGP </font>(<a
 href="/current/usrman.html#ref_15">15</a>).</div>
<p><br>
<!--SECTION-->
<!--IF--><a name="The_IF_line"></a></p>
<h4 class="subsubsection">4.2.13. The IF line</h4>
<div class="subsubsection">The Initiation Frequency lines reflect the
frequency
at which each nucleotide within the initiation region is found at the
5'end
of bone fide full-length cDNA clone inserts.</div>
<!--SECTION-->
<!--TX--><a name="The_TX_line"></a>
<h4 class="subsubsection">4.2.14. The TX line</h4>
The TX (TaXonomy) lines define a promoter's location within EPD's
hierarchical
classification system (see Section 5). <font color="#000000">Note that
starting from release 72, the <a
 href="/current/usrman.html#CLASSIFICATION">classification
system</a> is no longer maintained</font>.<br>
<!--SECTION-->
<!--KW--><a name="The_KW_line"></a>
<h4 class="subsubsection">4.2.15. The KW line</h4>
The KW lines define a number of <a
 href="/current/keywords.html">keywords
</a>describing
an entry.
<!--SECTION--><br>
<a name="The_FP,_DO_and_RF_lines"></a>
<h4 class="subsubsection">4.2.16. The FP, DO and RF lines</h4>
These lines pertain to the EPD old format, see next Section.&nbsp;<a
 name="The_//_line"></a>
<h4 class="subsubsection">4.2.17. The // line</h4>
The // (terminator) line contains no data or comments. It designates
the
end of an entry.
<br>
<a name="Line_types_retained_from_the_old_format"></a>
<h3 class="subsection">4.3. Line types retained from the old format</h3>
The last six lines of a entry present essential information in the more
concise, old format. A original description of the old format follows:
Each entry starts with an FP line that contains a position reference to
a transcription initiation site, and ends with a terminator (//).Below
is an example of a promoter entry:
<pre>FP   Hs c-myc         P2+:+S  EU:NC_000008.9       1+ 128817660; 11148.053 010*2<br>XX<br>DO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Experimental evidence: 4,4#,&lt;2&gt;<br>DO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Expression/Regulation: +mitogen<br>RF&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cell34:779&nbsp;&nbsp;&nbsp;&nbsp; EMBOJ2:2375&nbsp;&nbsp;&nbsp; MCB7:1393&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; MCB7:2988<br>//</pre>
<!--SECTION-->
<!--FP--><a name="The_FP_line"></a>
<h4 class="subsubsection">4.3.1. The FP line</h4>
The FP line contains the following fields and subfields:
<br>
<table style="width: 557px; height: 829px;">
  <caption>&nbsp; <br>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <td>
      <ul style="list-style-type: none;">
        <li> <b>columns</b></li>
      </ul>
      </td>
      <td>
      <ul style="list-style-type: none;">
        <li> <b>data type</b></li>
      </ul>
      </td>
    </tr>
    <tr>
      <td>
      <ul style="list-style-type: none;">
        <li>1- 2&nbsp;</li>
        <li>3- 5&nbsp;</li>
        <li>6-30&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>6-25&nbsp;</li>
          <li>26-26&nbsp;</li>
          <li>27-27&nbsp;</li>
          <li>28-28&nbsp;</li>
          <li>29-30&nbsp;</li>
        </ul>
        <li>31-55&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>31-51&nbsp;</li>
          <li>31-32&nbsp;</li>
          <li>33-33&nbsp;</li>
          <li>34-51&nbsp;</li>
          <li>52-52&nbsp;</li>
          <li>53-53&nbsp;</li>
          <li>54-63&nbsp;</li>
        </ul>
        <li>64-64&nbsp;</li>
        <li>65-70&nbsp;</li>
        <li>71-71&nbsp;</li>
        <li>72-74&nbsp;</li>
        <li>75-75&nbsp;</li>
        <li>76-80&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>76-78&nbsp;</li>
          <li>79-79&nbsp;</li>
          <li>80-80&nbsp;</li>
        </ul>
      </ul>
      </td>
      <td>
      <ul style="list-style-type: none;">
        <li>"FP"&nbsp;</li>
        <li>(blank)&nbsp;</li>
        <li>description:&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>promoter name&nbsp;</li>
          <li>":&nbsp;"</li>
          <li>independent subset status (see <a
 href="/current/usrman.html#HOMOLOGOUS_PROMOTERS">section
6</a>)&nbsp;</li>
          <li>type of initiation site (see <a
 href="/current/usrman.html#ASSIGNMENT_OF_TRANSCRIPTION_INITIATION_SITE">section
3</a>)&nbsp;</li>
          <li>(blank)&nbsp;</li>
        </ul>
        <li>functional position reference:&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>sequence reference:&nbsp;</li>
          <li>genome db code&nbsp;</li>
          <li>":"&nbsp;</li>
          <li>genome db entry accession number&nbsp;</li>
          <li>sequence type (0 = circular, 1 = linear)&nbsp;</li>
          <li>strand (+ or -)&nbsp;</li>
          <li>position number&nbsp;</li>
        </ul>
        <li>";"&nbsp;</li>
        <li>entry code&nbsp;</li>
        <li>"."&nbsp;</li>
        <li>homology group number (see <a
 href="/current/usrman.html#HOMOLOGOUS_PROMOTERS">section
6</a>)&nbsp;</li>
        <li>(blank)&nbsp;</li>
        <li>alternative promoter identification code:&nbsp;</li>
        <ul style="list-style-type: none;">
          <li>gene number&nbsp;</li>
          <li>"*"&nbsp;</li>
          <li>Initiation site number&nbsp;</li>
        </ul>
      </ul>
      </td>
    </tr>
  </tbody>
</table>
<a name="Explanations"></a>Explanations:
<ul>
  <li>The promoter name begins with a species code usually followed by
a gene
locus or gene product name. Species codes consist of the initials of
genus
and species name. Occasionally, three characters are required to
generate
unique codes. Standard abbreviations identify viruses. The full names
of
the organisms are given in appendix B.1. Subspecies or strains are
specified
in parentheses. <font color="#000000">Chromosomal locations (genetic
or
cytogenetic loci, genomic map units, etc.) may appear in square
brackets
immediately following species codes. Many gene products are referred to
by abbreviations explained in appendix B.3. Alternative promoters are
identified
by right-justified "P" and a digit indicating the corresponding
initiation
site numbered sequentially from 5' to 3'. An optional "E" and digit
refers
to the corresponding 5'exons, if known. Identical numbers indicate
3'co-terminal
exons. The strongest initiation site is marked by trailing + if known
(see
also <a href="/current/AP.html">List of
alternative
promoters</a>)</font></li>
  <li>genome db codes currently used are 'EM' for EMBL database, and
'EU' for genome contigs or chromosomal genome assemblies of the RefSeq
database.</li>
  <li>The EMBL accession number always relates to the first EMBL
cross-reference.
This one is usually the longest promoter region except when the entry
is
cancelled from the EMBL database, but still present in GenBank or DDBJ.</li>
  <li>The sequence type indicates whether the sequence is circular or
linear.
A sequence comprising exactly one repeat unit of a tandem repeat
cluster
is also considered circular. Note that the annotation as circular or
linear
sequences in EPD is not always in agreement with the corresponding
annotation
in EMBL.</li>
  <li>The entry code is a five-digit number which is the only part of a
promoter
entry that is stable from release to release.</li>
  <li>Alternative promoter identification code: Genes represented by
multiple
promoter entries in EPD are assigned a promoters group number. The
corresponding
initiation sites are numbered sequentially from 5' to 3'.</li>
</ul>
<!--SECTION-->
<!--DO--><a name="Documentation"></a>
<h4 class="subsubsection">4.3.2. DO lines: Documentation</h4>
Documentation of promoter entries is presented on lines starting with
"DO".
They are essentially free format and so far not processed by specific
programs.
In the present release, there are two DO lines per entry, the first
referring
to the transcript mapping experiments that define the promoter, the
second
giving information about expression and regulation.The varies
experimental
techniques are identified by number codes.The "Medline's number" and/or
"example" in brackets are linked, respectively, to the abstract and/ or
to the full text article describing the related experiment.
<br>
<a name="codes"></a><br>
<table>
  <caption>&nbsp; <br>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <th>codes</th>
      <th>experiments</th>
    </tr>
    <tr>
      <td width="35">1</td>
      <td>Direct RNA sequencing (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1634116">1634116</a>)</td>
    </tr>
    <tr>
      <td>2</td>
      <td valign="top">Length measurement of an RNA product (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1989694">1989694</a>)</td>
    </tr>
    <tr>
      <td valign="top">3</td>
      <td>Nuclease protection : Length measurement of a
nuclease-protected complementary
RNA or DNA fragment (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2845126">2845126</a>)
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8294473">8294473</a>)</td>
    </tr>
    <tr>
      <td valign="top">4</td>
      <td>RNA sequencing by primer extension : by dideoxy-terminated
primer extension
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3396543">3396543</a>)</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Sequencing of a full-length cDNA (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8294473">8294473</a>)</td>
    </tr>
    <tr>
      <td valign="top">6</td>
      <td>Primer extension : Length measurement of a primer extension
product&nbsp;
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10187799">10187799</a>
, <a href="http://www.jbc.org/cgi/content/full/274/15/10154/F3">example</a>)
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9880555">9880555</a>
, <a href="http://www.jbc.org/cgi/content/full/274/3/1736/F2">example</a>)</td>
    </tr>
    <tr>
      <td>7</td>
      <td>DNA sequencing of a full-length processed pseudogene (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3584116">3584116</a>)</td>
    </tr>
    <tr>
      <td valign="top">8</td>
      <td>Reverse direction primer extension with homologous sequence
ladder
: Length measurement of an in vitro synthesised DNA primed upstream of
the initiation site and blocked by the 5'end of the RNA hybridized to
the
template (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2451027">2451027</a>)</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Rapid amplification of cDNA ends (RACE) (<a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9116864&amp;dopt=Books">9116864</a>)</td>
    </tr>
    <tr>
      <td>10</td>
      <td>RNA sequencing, type not specifed</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Oligo-capping : artificial capping of mRNA followed by
sequencing of
the 5' end of cDNA (<a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11375929&amp;dopt=Books">11375929</a>,
      <a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11337467&amp;dopt=Books">11337467
and examples)</a></td>
    </tr>
    <tr>
      <td>12</td>
      <td>Mammalian gene collection (MGC) full-length cDNA cloning (<a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10521335&amp;dopt=Books">10521335
and example)</a></td>
    </tr>
    <tr>
      <td>13</td>
      <td>5' end confirmed by alignment of first 100 downstream
nucleotides to
EST database.</td>
    </tr>
    <tr>
      <td>14</td>
      <td>Oligo-capping: Berkeley Drosophila Genome Project (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12537569">12537569</a>)</td>
    </tr>
    <tr>
      <td style="vertical-align: top;">15</td>
      <td style="vertical-align: top;">Oligo-capping: Rice full-length
cDNA cloning
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12869764&amp;query_hl=2">12869764</a>)</td>
    </tr>
  </tbody>
</table>
<p>Special characters appended to the number codes designate an
experimental
gene expression system where the RNA for the corresponding experiments
was synthesized.
<br>
<table>
  <caption>&nbsp; <br>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <td width="35">*</td>
      <td>RNA POL II in vitro system</td>
    </tr>
    <tr>
      <td>o</td>
      <td>injected amphibian oocytes</td>
    </tr>
    <tr>
      <td>#</td>
      <td>transfected or transformed cells, injected neurons</td>
    </tr>
    <tr>
      <td>!</td>
      <td>transgenic organisms</td>
    </tr>
    <tr>
      <td><br>
      </td>
      <td><br>
      </td>
    </tr>
    <tr>
      <td>r</td>
      <td>experiments performed with closely related gene</td>
    </tr>
    <tr>
      <td valign="top">h</td>
      <td>homologous sequence ladder used for length measurement
of&nbsp; nuclease
protection or primer extension product</td>
    </tr>
    <tr>
      <td>l</td>
      <td>low-precision data (error &gt; +/- 5 bp)</td>
    </tr>
  </tbody>
</table>
Explanations and additional conventions:
</p>
<ul>
  <li>The full-length assumption of a cDNA clone or a proccessed
pseudogene
is
based on consistency with accompanying nuclease-protection or primer
extension
data or, alternatively, the existence of multiple 5'coterminal clones
or
pseudogenes.</li>
</ul>
The information on expression/regulation may include indication of
developmental
stages, tissues, cell types, cell cycle stages, and various regulatory
features.Conventions:
<ul>
  <li>Semicolon delimits the two fields : expression and regulation.</li>
  <li>Comma delimits alternative keywords (e.g. liver, kidney)</li>
  <li>"+" means "induced by" or "strongly expressed in".</li>
  <li>"-" means "repressed by" or "weakly expressed in".</li>
  <li>"~" means "modulated by".</li>
  <li>Cell cycle stages are given in square brackets.</li>
</ul>
<!--SECTION-->
<a name="Literature_references"></a>
<h4 class="subsubsection">4.3.3. RF line: Literature references</h4>
<div class="subsubsection">The first four references from the RN, RX,
RA,
RT and RL lines are repeated in a highly condensed form. Each reference
is spaced by 15 letters and indicates journal, volume, and starting
page
of the referred article (maximal 14 letters). The journal code
explained
in Appendix B.2.</div>
<p><br>
They primarily point to the articles where the experimental promoter
evidence is presented. Additional potential subjects are homology to
other
promoters, gene expression and regulation, nomenclature. Papers
containing
only sequence data are usually not referred to because they are easy to
find via the corresponding EMBL sequence entry descriptions.
<!--SECTION--><!--MISC--><br>
<a name="Miscellaneous"></a></p>
<h4 class="subsubsection">4.3.4. Miscellaneous</h4>
<ul>
  <li>Greek letters are sometimes represented by corresponding latin
letters
followed by apostrophe:</li>
  <br>
  <table>
    <caption>&nbsp; <br>
    </caption><tbody>
    </tbody><tbody>
    </tbody><tbody>
    </tbody> <tbody>
      <tr>
        <td>a' = alpha</td>
        <td>b' = beta</td>
        <td>g' = gamma</td>
        <td>d' = delta</td>
        <td>e' = epsilon</td>
      </tr>
      <tr>
        <td>z' = zeta</td>
        <td>h' = eta</td>
        <td>th'= theta</td>
        <td>k' = kappa</td>
        <td>l' = lambda</td>
      </tr>
      <tr>
        <td>n' = nu</td>
        <td>r' = rho</td>
      </tr>
    </tbody>
  </table>
  <li>Sub- and superscripts are sometimes indicated by preceding "_"
and "^",
respectively.</li>
</ul>
<!--SECTION-->
<!--Bulk_format-->
<h3 class="subsection"><a
 name="Distinct_format_of_preliminary_entries_in_epd_bulk.dat"></a></h3>
<h3 class="subsection">
4.4. Distinct format of 'preliminary' entries in epd_bulk.dat</h3>
<h4>
4.4.1. The title line:</h4>
<pre>TI&nbsp;&nbsp; epd83&nbsp;&nbsp;&nbsp;&nbsp; Bulk Section Eukaryotic Promoter Database / Release 83 EP</pre>
<h4 class="subsubsection">
4.4.2. The ID line</h4>
The identification line is always the first line of an entry. The form
of the ID line in 'epd_bulk.dat' is:
<pre>ID&nbsp;&nbsp; OS_bAAAA&nbsp;&nbsp;&nbsp;&nbsp; preliminary; undefined; TAXONOMIC DIVISION.</pre>
<ul>
  <li>An unique entry identifier "<span style="font-family: monospace;">OS_bAAAA</span>"
is contructed using the species identification code ('OS') with at most
4 alphanumeric characters representing the biological source of the
promoter
and a 'b' (for bulk) followed by an arbitrary 4 letter code</li>
  <li>"preliminary" <i>data class</i> field indicates that the entry
has not
(yet) undergone all quality checks necessary for being classified as
"standard".</li>
  <li>"undefined" as <i>initiation site type</i> due to insufficient
data to
define transcription initiation patterns (<a
 href="/current/usrman.html#ASSIGNMENT_OF_TRANSCRIPTION_INITIATION_SITE">Section
3</a>).</li>
  <li> <i>TAXONOMIC DIVISION</i> are</li>
  <ul>
    <li>PLN for plant</li>
    <li>NEM for nematode</li>
    <li>ART for arthropode</li>
    <li>MLS for mollusc</li>
    <li>ECH for echinoderm</li>
    <li>VRT for vertebrates.</li>
  </ul>
Note that these codes relate to the organism in which the promoter is
expressed,
not to the source organism in which the promoter is replicated as
defined
on the OS line.
</ul>
The ID line is terminated by a period.
<h4 class="subsubsection">4.4.3. The AC line</h4>
<pre>AC&nbsp;&nbsp; EP00001;</pre>
The accession number consists of the character string "<tt>EP</tt>"
followed
by 5 digits. Previously the first two digits of the AC designated the
release
number of initial appearance of the specific entry followed by the EPD
entry order. AC numbers in 'epd_bulk.dat' are continuous numbers,
excluding
ACs already used for entries in the main file 'epd.dat'.
<!--SECTION--><!--CLASSIF-->
<p><a name="CLASSIFICATION"></a></p>
<h2 class="section">5 CLASSIFICATION</h2>
<div class="MsoNormal"><b><font color="#000000">Starting from release
72,
the classification system is no longer maintained. New entries are
presently
added by default to an '?Unclassified' category. The classification
system
might still provide valuable information for entries added before
release
72. However for any category, consider the possible existence of
additional,
potentially corresponding EPD entries in the default categories.</font></b></div>
<p><br>
<i>The entries of the Eukaryotic Promoter Database are embedded
in a hierarchical
<a href="/current/epd_classif.html">classification</a>
system. A promoter's taxonomic location is made clear by interspersed
group
headings. The example shown below is taken from top of the database. A
contrasting format has been chosen to emphasize the very different
nature
of this information.</i>
</p>
<pre><i>*----------------------------------------------------------------------*<br>*&nbsp;&nbsp;&nbsp; 1. Plant promoters&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *<br>*----------------------------------------------------------------------*<br>*&nbsp;&nbsp;&nbsp; 1.1. Chromosomal genes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *<br>*----------------------------------------------------------------------*<br>*&nbsp;&nbsp;&nbsp; 1.1.1. Small nuclear RNAs&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *<br>*----------------------------------------------------------------------*</i></pre>
<i>A group heading consists of a series of node numbers and a title.
The
highest classification level distinguishes between promoters active in
major eukaryotic taxa (phyla). Further below, grouping considers
replicon
type and functional properties of gene products. On the lowest level,
homology
(as defined in section 6) is the criterion. A survey of the upper part
of the classification pyramid is presented in appendix A.The proposed
classification
system has a highly tentative character as it is often unclear how a
new
promoter should be classified, especially if the gene product is a
multifunctional
protein. Users should therefore not be surprised or discouraged if they
don't find a promoter at the initially expected place.</i>
<br>
<!--SECTION-->
<!--HG--><a name="HOMOLOGOUS_PROMOTERS"></a>
<h2 class="section">6 HOMOLOGOUS PROMOTERS</h2>
Homology is defined as sequence similarity due to common phylogenetic
origin.
In EPD, two promoters are considered homologous if they exhibit
&gt;=50% sequence
similarity between -79 and +20. Similarity is calculated from optimal
alignments
generated with the aid of the UWGCG subroutine ShiftAlign (<a
 href="/current/usrman.html#ref_13">13</a>)
using the following symbol comparison table:
<center><br>
<table>
  <caption>&nbsp;
  <center>
  <p></p>
  </center>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <td>A</td>
      <td>C</td>
      <td>G</td>
      <td>N</td>
      <td>T</td>
      <td><br>
      </td>
    </tr>
    <tr>
      <td>1.0</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>0.5</td>
      <td>0.0</td>
      <td>A</td>
    </tr>
    <tr>
      <td><br>
      </td>
      <td>1.0</td>
      <td>0.0</td>
      <td>0.5</td>
      <td>0.0</td>
      <td>C</td>
    </tr>
    <tr>
      <td><br>
      </td>
      <td><br>
      </td>
      <td>1.0</td>
      <td>0.5</td>
      <td>0.0</td>
      <td>G</td>
    </tr>
    <tr>
      <td><br>
      </td>
      <td><br>
      </td>
      <td><br>
      </td>
      <td>0.5</td>
      <td>0.5</td>
      <td>N</td>
    </tr>
    <tr>
      <td><br>
      </td>
      <td><br>
      </td>
      <td><br>
      </td>
      <td><br>
      </td>
      <td>1.0</td>
      <td>T</td>
    </tr>
  </tbody>
</table>
</center>
<p>Gap weight and gap length weight are specified as 3 and 0,
respectively.
Terminal gaps are ignored. Percent similarity is understood as
alignment
score divided by segment length, times 100. Groups of homologous
promoters
are identified by homology group numbers (see 4.2.1.). Definition of
these
groups is based on similarity scores as defined above and a tree
generation
method called UPGMA (<a
 href="/current/usrman.html#ref_14">14</a>)<font
 color="#000000">.
In a few cases, similarities </font>between 50% and 56% were ignored<font
 color="#000000">
if the protein sequences of the corresponding genes were not related.
Similarities
were also ignored between alternative promoter sequences that are
spaced
by less than 50 bp</font>. A subset of "independent" promoters is
marked
by "+" in column 27 of the FP line. This set contains only one member
per
homology group (usually, the promoter with the longest upstream
sequence
available) and is intended to be used for statistical analysis of
functional
patterns where it is important to avoid bias by multiples of closely
related
sequences.
<!--SECTION--><br>
<a name="PROMOTER_SEQUENCE_RETRIEVAL"></a></p>
<h2 class="section">7 PROMOTER SEQUENCE RETRIEVAL</h2>
Promoter sequence listings have not been incorporated into EPD for two
reasons: (i) to avoid duplication of data already existing elsewhere in
the EMBL data library, and (ii) to encourage usage of FPS-dependent
sequence
retrieval programs which enables the user to specify suitable 5'- and
3'boundaries
of the requested sequence segments himself. Effort is under way to
motivate
producers of standard nucleotide sequence analysis packages to provide
such tools in the future. In the meantime, users with some programming
experience will find it easy to write their own routines. Our local
sequence
extraction programs run in a UWGCG environment (<a
 href="/current/usrman.html#ref_13">13</a>)
and have been implemented at several sites in Europe and the United
States.
They are documented and freely available on request.
<!--SECTION--><!--REFS--><br>
<a name="REFERENCES"></a>
<h2 class="section">8 REFERENCES</h2>
<ol>
  <a name="ref_1"></a><li>Bucher, P. &amp; Trifonov, E.N., <i>Compilation
and analysis of eukaryotic
POL II promoter sequences</i>, Nucl. Acids Res. <b>14</b>, 10009-10026
(1986). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=3808945">3808945</a>)</li>
  <br>
  <a name="ref_2"></a><li>Bucher, P. &amp; Bryan, B., <i>Signal search
analysis: a new method to
localize and characterize functionally important DNA sequences</i>,
Nucl.
Acids Res. <b>12</b>, 287-305 (1984). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=6546421">6546421</a>)</li>
  <br>
  <a name="ref_3"></a><li>Stoesser, G., Tuli,M.A., Lopez, R. and Sterk,
P., <i>The EMBL
nucleotide
sequence database</i>, Nucleic Acids. Res., <b>27</b>,<b> </b>18-24
(1999).
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847133">9847133</a>)</li>
  <br>
  <a name="ref_4"></a><li>Benson, D.A., Boguski, M.S., Lipman, D.J.,
Ostell, J., Ouellette
B.F.F,&nbsp;
Rapp, B:A: and Wheeler, D.L., <i>GenBank,</i> Nucleic Acids. Res., <b>27</b>,
12-17 (1999). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847132">9847132</a>)</li>
  <br>
  <a name="ref_5"></a><li>Sugawara,&nbsp; H., Miyazaki, S., Gojobori,
T. and Tateno, Y.,<i>DNA
Data
Bank of Japan dealing with large-scale data submission</i>, Nucleic
Acids.
Res., <b>27</b>, 25-28 (1999). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847134">9847134</a>)</li>
  <br>
  <a name="ref_6"></a><li>Bairoch, A. and Apweiler, R., <i>The
SWISS-PROT protein sequence data
bank
and its supplement TrEMBL in 1999</i>, Nucleic Acids Res., <b>27</b>,
49-54
(1999). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847139">9847139</a>)</li>
  <br>
  <a name="ref_7"></a><li>Heinemeyer, T., Chen, X., Karas, H., Kel,
A.E., Kel, O.V., Liebich, I.,
Meinhardt, T., Reuter, I., Schacherer, F. and Wingender, E., <i>Expanding
the TRANSFAC database towards an expert system of regulatory molecular
mechanisms</i>, Nucleic Acids. Res., <b>27</b>,<b> </b>318-322
(1999).
(<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847216">9847216</a>)</li>
  <br>
  <a name="ref_8"></a><li>The FlyBase consortium, <i>The FlyBase
database of the drosophilia
genome
projects and community litterature</i>, Nucleic Acids. Res., <b>27</b>,85-88
(1999). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847148">9847148</a>)</li>
  <br>
  <a name="ref_9"></a><li>Pearson, P., Francomano, C., Foster, P.,
Bocchini, C., Li, P. and
McKusick,
V., <i>The status of online Mendelian inheritance in man (OMIM) medio
1994, </i>Nucleic
Acids Res., <b>22</b>, 3470-3473 (1994). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=7937048">7937048</a>)</li>
  <br>
  <a name="ref_10"></a><li>Blake, J.A., Richardson, J.E., Davisson,
M.T., Eppig, J.T. and the
Mouse
Genome Database Group, <i>The Mouse Genome Database (MGD): genetic and
genomic information about the laboratory mouse</i>, Nucleic Acids Res.,
    <b>27</b>,
95-98 (1999). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=9847150">9847150</a>)</li>
  <br>
  <a name="ref_11"></a><li>Suzuki Y., Yamashita R., Nakai K., Sugano
S., <i>DBTSS: database of
human
transcriptional start sites and full-length cDNAs. </i>Nucleic Acids
Res. <b>30</b>(1):328-331(2002).
(<a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11752328&amp;dopt=Books">11752328</a>)</li>
  <br>
  <a name="ref_12"></a><li>Strausberg, R.L., Feingold, E.A., Klausner,
R.D., Collins, F.S., <i>The
Mammalian Gene Collection. </i>Science, <b>286</b>, 455-457 (1999). (<a
 href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10521335&amp;dopt=Books">10521335)</a></li>
  <br>
  <a name="ref_13"></a><li>Devereux,J., Haeberli,P., &amp; Smithies,O. <i>A
comprehensive set of
sequence
analysis programs for the VAX</i>, Nucl. Acids Res. <b>12</b>, 387-395
(1984). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=6546423">6546423</a>)</li>
  <br>
  <a name="ref_14"></a><li>Sneath,H.A. &amp; Sokal,R.R., <i>Numerical
taxonomy</i>, W.H.
Freemann,
San Francisco, London (1973).</li>
  <br>
  <a name="ref_15"></a><li>Stapleton M., Liao GC., Brokstein P., Hong
L., Carninci P., Shiraki T.,
Hayashizaki Y., Champe M., Pacleb J., Wan K., Yu C., Carlson J., George
R., Celniker S., and Rubin GM., <i>The Drosophila Gene Collection:
Identification
of Putative Full-Length cDNAs for 70% of D. melanogaster Genes. </i>Genome
Res., <b>12</b>:1294-1300 (2002). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=12176937">12176937</a>)</li>
  <br>
  <a name="ref_16"></a><li>Schmid C.D., Praz V., Delorenzi M.,
P&eacute;rier R., and Bucher
P.,&nbsp;<span style="font-style: italic;">The
Eukaryotic Promoter Database EPD: the impact of in silico primer
extension.</span>
Nucleic Acids Res. <b>32,</b> D82-5 (2004). (<a
 href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Retrieve&amp;dopt=Citation&amp;list_uids=14681364">14681364</a>)</li>
<!--SECTION--> <br>
&nbsp;
</ol>
<a name="SURVEY_OF_RELEASE"></a>
<h2 class="section">A.&nbsp; APPENDIX A : <a
 href="/current/SURVEY.html">SURVEY
OF RELEASE</a></h2>
<p><br>
<a name="APPENDIXB"></a></p>
<h2 class="section">B.&nbsp; APPENDIX B : CODES AND ABBREVIATIONS</h2>
<a name="SPECIES_CODES"></a>
<h3 class="subappendix">B.1. SPECIES CODES</h3>
<center><br>
<table>
  <caption>&nbsp;
  <center>
  <p></p>
  </center>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <td><b>Code</b></td>
      <th><i>Scientific name</i> (English name)</th>
    </tr>
    <tr>
      <td>AAV2</td>
<!--#http://www.ncbi.nlm.nih.gov/htbin-post/Taxonomy/wgetorg?name=Adeno-associated%20virus%202&amp;srchmode=1-->
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Adeno-associated+virus&amp;lvl=0&amp;srchmode=1">Adeno-associated
virus 2</a></i></td>
    </tr>
    <tr>
      <td>Ac</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Aplysia+californica&amp;lvl=0&amp;srchmode=1">Aplysia
californica</a></i> (California sea hare)</td>
    </tr>
    <tr>
      <td>AcNPV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Autographa+californica+nuclear+polyhedrosis+virus&amp;lvl=0&amp;srchmode=1">Autographa
californica nuclear polyhedrosis virus</a></i></td>
    </tr>
    <tr>
      <td>Ad2</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+adenovirus+type+2&amp;lvl=0&amp;srchmode=1">Human
adenovirus type 2</a></i></td>
    </tr>
    <tr>
      <td>Ad5</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+adenovirus+type+5&amp;lvl=0&amp;srchmode=1">Human
adenovirus type 5</a></i></td>
    </tr>
    <tr>
      <td>Ad7</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+adenovirus+type+7&amp;lvl=0&amp;srchmode=1">Human
adenovirus type 7</a></i></td>
    </tr>
    <tr>
      <td>Ad12</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+adenovirus+type+12&amp;lvl=0&amp;srchmode=1">Human
adenovirus type 12</a></i></td>
    </tr>
    <tr>
      <td>Ag</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Ateles+geoffroyi&amp;lvl=0&amp;srchmode=1">Ateles
geoffroyi</a></i> (black-handed spider monkey)</td>
    </tr>
    <tr>
      <td>ALV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Avian+leukosis+virus&amp;lvl=0&amp;srchmode=1">Avian
leukosis virus</a></i></td>
    </tr>
    <tr>
      <td>Am</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Antirrhinum+majus&amp;lvl=0&amp;srchmode=1">Antirrhinum
majus</a></i> (snapdragon)</td>
    </tr>
    <tr>
      <td>Ab-MLV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Abelson+murine+leukemia+virus&amp;lvl=0&amp;srchmode=1">Abelson
murine leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>Apo</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Antheraea+polyphemus&amp;lvl=0&amp;srchmode=1">Antheraea
polyphemus</a></i> (polyphemus moth)</td>
    </tr>
    <tr>
      <td>Ap</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Anas+platyrhynchos&amp;lvl=0&amp;srchmode=1">Anas
platyrhynchos</a></i> (mallard, domestic duck)</td>
    </tr>
    <tr>
      <td>As</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Avena+sativa&amp;lvl=0&amp;srchmode=1">Avena
sativa</a></i> (oat)</td>
    </tr>
    <tr>
      <td>At</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Agrobacterium+tumefaciens&amp;lvl=0&amp;srchmode=1">Agrobacterium
tumefaciens</a></i></td>
    </tr>
    <tr>
      <td>Ath</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Arabidopsis+thaliana&amp;lvl=0&amp;srchmode=1">Arabidopsis
thaliana</a></i> (thale cress)</td>
    </tr>
    <tr>
      <td>Atr</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Aotus+trivirgatus&amp;lvl=0&amp;srchmode=1">Aotus
trivirgatus</a></i> (douroucouli)</td>
    </tr>
    <tr>
      <td>Ay</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Antheraea+yamamai&amp;lvl=0&amp;srchmode=1">Antheraea
yamamai</a></i></td>
    </tr>
    <tr>
      <td>B19</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+parvovirus+B19&amp;lvl=0&amp;srchmode=1">Human
parvovirus B19</a></i></td>
    </tr>
    <tr>
      <td>Be</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Bertholletia+excelsa&amp;lvl=0&amp;srchmode=1">Bertholletia
excelsa</a></i> (Brazil nut)</td>
    </tr>
    <tr>
      <td>BKV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Papovavirus+BKV&amp;lvl=0&amp;srchmode=1">Papovavirus
BKV</a></i></td>
    </tr>
    <tr>
      <td>BLV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Bovine+leukemia+virus&amp;lvl=0&amp;srchmode=1">Bovine
leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>Bm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Bombyx+mori&amp;lvl=0&amp;srchmode=1">Bombyx
mori</a></i> (silkworm)</td>
    </tr>
    <tr>
      <td>Bn</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Brassica+napus&amp;lvl=0&amp;srchmode=1">Brassica
napus</a></i> (rape)</td>
    </tr>
    <tr>
      <td>BPV1</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Bovine+papillomavirus+type+1&amp;lvl=0&amp;srchmode=1">Bovine
papillomavirus type 1</a></i></td>
    </tr>
    <tr>
      <td>Bt</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Bos+taurus&amp;lvl=0&amp;srchmode=1">Bos
taurus</a></i> (cattle)</td>
    </tr>
    <tr>
      <td>CaMV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Cauliflower+mosaic+virus&amp;lvl=0&amp;srchmode=1">Cauliflower
mosaic virus</a></i></td>
    </tr>
    <tr>
      <td>Cco</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Coturnix+coturnix&amp;lvl=0&amp;srchmode=1">Coturnix
coturnix</a></i> (quail)</td>
    </tr>
    <tr>
      <td>Ce</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Caenorhabditis+elegans&amp;lvl=0&amp;srchmode=1">Caenorhabditis
elegans</a></i></td>
    </tr>
    <tr>
      <td>Cg</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Canavalia+gladiata&amp;lvl=0&amp;srchmode=1">Canavalia
gladiata</a></i> (sword bean)</td>
    </tr>
    <tr>
      <td>Cgr</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Cricetulus+griseus&amp;lvl=0&amp;srchmode=1">Cricetulus
griseus</a></i> (Chinese hamster)</td>
    </tr>
    <tr>
      <td>Ch</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Capra+hircus&amp;lvl=0&amp;srchmode=1">Capra
hircus</a></i> (goat)</td>
    </tr>
    <tr>
      <td>Cl</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Canis+lupus&amp;lvl=0&amp;srchmode=1">Canis
lupus</a></i> (gray wolf)</td>
    </tr>
    <tr>
      <td>Cm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Cairina+moschata&amp;lvl=0&amp;srchmode=1">Cairina
moschata</a></i> (muscovy duck)</td>
    </tr>
    <tr>
      <td>Cp</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Cavia+porcellus&amp;lvl=0&amp;srchmode=1">Cavia
porcellus</a></i> (domestic guinea pig)</td>
    </tr>
    <tr>
      <td>Cpe</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Cucurbita+pepo&amp;lvl=0&amp;srchmode=1">Cucurbita
pepo</a></i> (zucchini)</td>
    </tr>
    <tr>
      <td>Ct</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Chironomus+thummi&amp;lvl=0&amp;srchmode=1">Chironomus
thummi</a></i> (midge)</td>
    </tr>
    <tr>
      <td>Cte</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Chironomus+tentans&amp;lvl=0&amp;srchmode=1">Chironomus
tentans</a></i></td>
    </tr>
    <tr>
      <td>Dc</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Daucus+carota&amp;lvl=0&amp;srchmode=1">Daucus
carota</a></i> (carrot)</td>
    </tr>
    <tr>
      <td>Df</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+funebris&amp;lvl=0&amp;srchmode=1">Drosophila
funebris</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dh</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+hydei&amp;lvl=0&amp;srchmode=1">Drosophila
hydei</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>DHBV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Duck+hepatitis+B+virus&amp;lvl=0&amp;srchmode=1">Duck
hepatitis B virus</a></i></td>
    </tr>
    <tr>
      <td>Dm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+melanogaster&amp;lvl=0&amp;srchmode=1">Drosophila
melanogaster</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dma</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+mauritiana&amp;lvl=0&amp;srchmode=1">Drosophila
mauritiana</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dmo</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+mojavensis&amp;lvl=0&amp;srchmode=1">Drosophila
mojavensis</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dmu</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+mulleri&amp;lvl=0&amp;srchmode=1">Drosophila
mulleri</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Do</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+orena&amp;lvl=0&amp;srchmode=1">Drosophila
orena</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dp</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+pseudoobscura&amp;lvl=0&amp;srchmode=1">Drosophila
pseudoobscura</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Ds</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+simulans&amp;lvl=0&amp;srchmode=1">Drosophila
simulans</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dse</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+sechellia&amp;lvl=0&amp;srchmode=1">Drosophila
sechellia</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>Dv</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Drosophila+virilis&amp;lvl=0&amp;srchmode=1">Drosophila
virilis</a></i> (fruit fly)</td>
    </tr>
    <tr>
      <td>EBV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+herpesvirus+4&amp;lvl=0&amp;srchmode=1">Human
herpesvirus 4</a></i> (Epstein-Barr virus)</td>
    </tr>
    <tr>
      <td>Ec</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Equus+caballus&amp;lvl=0&amp;srchmode=1">Equus
caballus</a></i> (horse)</td>
    </tr>
    <tr>
      <td>FBJ-MSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Murine+osteosarcoma+virus&amp;lvl=0&amp;srchmode=1">Murine
osteosarcoma virus</a></i> (Finkel-Biskis-Jinkins)</td>
    </tr>
    <tr>
      <td>FBR-MSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Murine+osteosarcoma+virus&amp;lvl=0&amp;srchmode=1">Murine
osteosarcoma virus</a></i> (Finkel-Biskis-Reilly)</td>
    </tr>
    <tr>
      <td>F-MCF</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Friend+mink+cell+focus-forming+virus&amp;lvl=0&amp;srchmode=1">Friend
mink cell focus-forming virus</a></i> (Murine)</td>
    </tr>
    <tr>
      <td>Fs</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Felis+silvestris&amp;lvl=0&amp;srchmode=1">Felis
silvestris</a></i> (wild cat)</td>
    </tr>
    <tr>
      <td>F-SFFV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Friend+spleen+focus-forming+virus&amp;lvl=0&amp;srchmode=1">Friend
spleen focus-forming virus</a></i></td>
    </tr>
    <tr>
      <td>Ft</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Flaveria+trinervia&amp;lvl=0&amp;srchmode=1">Flaveria
trinervia</a></i></td>
    </tr>
    <tr>
      <td>GA-FeLV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Gardner-Arnstein+feline+leukemia+oncovirus+B&amp;lvl=0&amp;srchmode=1">Gardner-Arnstein
feline leukemia oncovirus B</a></i></td>
    </tr>
    <tr>
      <td>GALV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Gibbon+ape+leukemia+virus&amp;lvl=0&amp;srchmode=1">Gibbon
ape leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>Gg</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Gallus+gallus&amp;lvl=0&amp;srchmode=1">Gallus
gallus</a></i> (chicken)</td>
    </tr>
    <tr>
      <td>Ggo</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Gorilla+gorilla&amp;lvl=0&amp;srchmode=1">Gorilla
gorilla</a></i> (gorilla)</td>
    </tr>
    <tr>
      <td>Gm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Glycine+max&amp;lvl=0&amp;srchmode=1">Glycine
max</a></i> (soybean)</td>
    </tr>
    <tr>
      <td>GSHV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Ground+squirrel+hepatitis+virus&amp;lvl=0&amp;srchmode=1">Ground
squirrel hepatitis virus</a></i></td>
    </tr>
    <tr>
      <td>H-1</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Parvovirus+H1&amp;lvl=0&amp;srchmode=1">Parvovirus
H1</a></i> (Murine)</td>
    </tr>
    <tr>
      <td>Ha</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Helianthus+annuus&amp;lvl=0&amp;srchmode=1">Helianthus
annuus</a></i> (common sunflower)</td>
    </tr>
    <tr>
      <td>Hb</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Hevea+brasiliensis&amp;lvl=0&amp;srchmode=1">Hevea
brasiliensis</a></i> (para rubber tree)</td>
    </tr>
    <tr>
      <td>HBV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+hepatitis+B+virus&amp;lvl=0&amp;srchmode=1">Human
hepatitis B virus</a></i></td>
    </tr>
    <tr>
      <td>HCMV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+cytomegalovirus&amp;lvl=0&amp;srchmode=1">Human
cytomegalovirus</a></i></td>
    </tr>
    <tr>
      <td>Hg</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Halichoerus+grypus&amp;lvl=0&amp;srchmode=1">Halichoerus
grypus</a></i> (grey seal)</td>
    </tr>
    <tr>
      <td>HIV-1</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+immunodeficiency+virus+type+1&amp;lvl=0&amp;srchmode=1">Human
immunodeficiency virus type 1</a></i></td>
    </tr>
    <tr>
      <td>HIV-2</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+immunodeficiency+virus+type+2&amp;lvl=0&amp;srchmode=1">Human
immunodeficiency virus type 2</a></i></td>
    </tr>
    <tr>
      <td>HPV16</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+papillomavirus+type+16&amp;lvl=0&amp;srchmode=1">Human
papillomavirus type 16</a></i></td>
    </tr>
    <tr>
      <td>HPV18</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+papillomavirus+type+18&amp;lvl=0&amp;srchmode=1">Human
papillomavirus type 18</a></i></td>
    </tr>
    <tr>
      <td>Hs</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Homo+sapiens&amp;lvl=0&amp;srchmode=1">Homo
sapiens</a></i> (human)</td>
    </tr>
    <tr>
      <td>HSV-1</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+herpesvirus+1&amp;lvl=0&amp;srchmode=1">Human
herpesvirus 1</a></i></td>
    </tr>
    <tr>
      <td>HSV-2</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+herpesvirus+2&amp;lvl=0&amp;srchmode=1">Human
herpesvirus 2</a></i></td>
    </tr>
    <tr>
      <td>HTLV-I</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+T-cell+leukemia+virus+type+I&amp;lvl=0&amp;srchmode=1">Human
T-cell leukemia virus type I</a></i></td>
    </tr>
    <tr>
      <td>HTLV-II</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Human+T-cell+leukemia+virus+type+II&amp;lvl=0&amp;srchmode=1">Human
T-cell leukemia virus type II</a></i></td>
    </tr>
    <tr>
      <td>Hv</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Hordeum+vulgare&amp;lvl=0&amp;srchmode=1">Hordeum
vulgare</a></i> (barley)</td>
    </tr>
    <tr>
      <td>HVS</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Herpesvirus+saimiri&amp;lvl=0&amp;srchmode=1">Herpesvirus
saimiri</a></i></td>
    </tr>
    <tr>
      <td>JCV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=human+polyomavirus+JCV&amp;lvl=0&amp;srchmode=1">Human
polyomavirus JCV</a></i></td>
    </tr>
    <tr>
      <td>Le</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Lycopersicon+esculentum&amp;lvl=0&amp;srchmode=1">Lycopersicon
esculentum</a></i> (tomato)</td>
    </tr>
    <tr>
      <td>Leu</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Lepus+europaeus&amp;lvl=0&amp;srchmode=1">Lepus
europaeus</a></i> (European hare)</td>
    </tr>
    <tr>
      <td>Lm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Locusta+migratoria&amp;lvl=0&amp;srchmode=1">Locusta
migratoria</a></i> (migratory locust)</td>
    </tr>
    <tr>
      <td>Lp</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Lytechinus+pictus&amp;lvl=0&amp;srchmode=1">Lytechinus
pictus</a></i> (painted urchin)</td>
    </tr>
    <tr>
      <td>Lpe</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Lycopersicon+peruvianum&amp;lvl=0&amp;srchmode=1">Lycopersicon
peruvianum</a></i> (Peruvian tomato)</td>
    </tr>
    <tr>
      <td>Lv</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Lytechinus+variegatus&amp;lvl=0&amp;srchmode=1">Lytechinus
variegatus</a></i> (green urchin)</td>
    </tr>
    <tr>
      <td>Ma</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Mesocricetus+auratus&amp;lvl=0&amp;srchmode=1">Mesocricetus
auratus</a></i> (golden hamster)</td>
    </tr>
    <tr>
      <td>Mc</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Macaca+fascicularis&amp;lvl=0&amp;srchmode=1">Macaca
fascicularis</a></i> (crab-eating macaque)</td>
    </tr>
    <tr>
      <td>MCMV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Murine+cytomegalovirus&amp;lvl=0&amp;srchmode=1">Murine
cytomegalovirus</a></i></td>
    </tr>
    <tr>
      <td>MLV_AKV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=AKV+murine+leukemia+virus&amp;lvl=0&amp;srchmode=1">AKV
murine leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>MLVxeno</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Xenotropic+murine+leukemia+virus&amp;lvl=0&amp;srchmode=1">Xenotropic
murine leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>Mm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Mus+musculus&amp;lvl=0&amp;srchmode=1">Mus
musculus</a></i> (house mouse)</td>
    </tr>
    <tr>
      <td>M-MLV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Moloney+murine+leukemia+virus&amp;lvl=0&amp;srchmode=1">Moloney
murine leukemia virus</a></i></td>
    </tr>
    <tr>
      <td>M-MSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Moloney+murine+sarcoma+virus&amp;lvl=0&amp;srchmode=1">Moloney
murine sarcoma virus</a></i></td>
    </tr>
    <tr>
      <td>MMTV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Mouse+mammary+tumor+virus&amp;lvl=0&amp;srchmode=1">Mouse
mammary tumor virus</a></i></td>
    </tr>
    <tr>
      <td>Ms</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Medicago+sativa&amp;lvl=0&amp;srchmode=1">Medicago
sativa</a></i> (alfalfa)</td>
    </tr>
    <tr>
      <td>MSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Maize+streak+virus&amp;lvl=0&amp;srchmode=1">Maize
streak virus</a></i></td>
    </tr>
    <tr>
      <td>Np</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Nicotiana+plumbaginifolia&amp;lvl=0&amp;srchmode=1">Nicotiana
plumbaginifolia</a></i> (curled-leaved tobacco)</td>
    </tr>
    <tr>
      <td>Ns</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Nicotiana+sylvestris&amp;lvl=0&amp;srchmode=1">Nicotiana
sylvestris</a></i> (wood tobacco)</td>
    </tr>
    <tr>
      <td>Nt</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Nicotiana+tabacum&amp;lvl=0&amp;srchmode=1">Nicotiana
tabacum</a></i> (common tobacco)</td>
    </tr>
    <tr>
      <td>Nto</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Nicotiana+tomentosiformis&amp;lvl=0&amp;srchmode=1">Nicotiana
tomentosiformis</a></i></td>
    </tr>
    <tr>
      <td>Oa</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Ovis+aries&amp;lvl=0&amp;srchmode=1">Ovis
aries</a></i> (sheep)</td>
    </tr>
    <tr>
      <td>Oc</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Oryctolagus+cuniculus&amp;lvl=0&amp;srchmode=1">Oryctolagus
cuniculus</a></i> (rabbit)</td>
    </tr>
    <tr>
      <td>Os</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Oryza+sativa&amp;lvl=0&amp;srchmode=1">Oryza
sativa</a></i> (rice)</td>
    </tr>
    <tr>
      <td>Ph</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Petunia+hybrida&amp;lvl=0&amp;srchmode=1">Petunia
hybrida</a></i> (e.g. Petunia strain Mitchell)</td>
    </tr>
    <tr>
      <td>Pa</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Papio+anubis&amp;lvl=0&amp;srchmode=1">Papio
anubis</a></i> (olive baboon)</td>
    </tr>
    <tr>
      <td>Pc</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Petroselinum+crispum&amp;lvl=0&amp;srchmode=1">Petroselinum
crispum</a></i> (parsley)</td>
    </tr>
    <tr>
      <td>Pl</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Paracentrotus+lividus&amp;lvl=0&amp;srchmode=1">Paracentrotus
lividus</a></i> (common urchin)</td>
    </tr>
    <tr>
      <td>Pm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Psammechinus+miliaris&amp;lvl=0&amp;srchmode=1">Psammechinus
miliaris</a></i> (sand urchin)</td>
    </tr>
    <tr>
      <td>Polyoma</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Mouse+polyomavirus&amp;lvl=0&amp;srchmode=1">Mouse
polyomavirus</a></i></td>
    </tr>
    <tr>
      <td>Ppy</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Photinus+pyralis&amp;lvl=0&amp;srchmode=1">Photinus
pyralis</a></i> (North American firefly)</td>
    </tr>
    <tr>
      <td>Pp</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Pongo+pygmaeus&amp;lvl=0&amp;srchmode=1">Pongo
pygmaeus</a></i> (orangutan)</td>
    </tr>
    <tr>
      <td>Ps</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Pisum+sativum&amp;lvl=0&amp;srchmode=1">Pisum
sativum</a></i> (pea)</td>
    </tr>
    <tr>
      <td>Pt</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Pan+troglodytes&amp;lvl=0&amp;srchmode=1">Pan
troglodytes</a></i> (chimpanzee)</td>
    </tr>
    <tr>
      <td>Pth</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Pinus+thunbergii&amp;lvl=0&amp;srchmode=1">Pinus
thunbergii</a></i> (Japanese black pine)</td>
    </tr>
    <tr>
      <td>Pv</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Phaseolus+vulgaris&amp;lvl=0&amp;srchmode=1">Phaseolus
vulgaris</a></i> (kidney bean)</td>
    </tr>
    <tr>
      <td>RAV2</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Rous+associated+virus+type+2&amp;lvl=0&amp;srchmode=1">Rous
associated virus type 2</a></i> (Avian)</td>
    </tr>
    <tr>
      <td>Rc</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Ricinus+communis&amp;lvl=0&amp;srchmode=1">Ricinus
communis</a></i> (castor bean)</td>
    </tr>
    <tr>
      <td>R-MCF</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Rauscher+mink+cell+focus-forming+virus&amp;lvl=0&amp;srchmode=1">Rauscher
mink cell focus-forming virus</a></i></td>
    </tr>
    <tr>
      <td>Rn</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Rattus+norvegicus&amp;lvl=0&amp;srchmode=1">Rattus
norvegicus</a></i> (Norway rat)</td>
    </tr>
    <tr>
      <td>RSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Rous+sarcoma+virus&amp;lvl=0&amp;srchmode=1">Rous
sarcoma virus</a></i> (Avian)&nbsp;</td>
    </tr>
    <tr>
      <td>Sa</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Sinapis+alba&amp;lvl=0&amp;srchmode=1">Sinapis
alba</a></i> (white mustard)</td>
    </tr>
    <tr>
      <td>SA7P</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Simian+adenovirus+&amp;lvl=0&amp;srchmode=1">Simian
adenovirus (7P)</a></i></td>
    </tr>
    <tr>
      <td>Sd</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Strongylocentrotus+droebachiensis&amp;lvl=0&amp;srchmode=1">Strongylocentrotus
droebachiensis</a></i></td>
    </tr>
    <tr>
      <td>Se</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Nannospalax+ehrenbergi&amp;lvl=0&amp;srchmode=1">Nannospalax
ehrenbergi </a></i> (Ehrenberg's mole-rat)</td>
    </tr>
    <tr>
      <td>Sg</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Oncorhynchus+mykiss&amp;lvl=0&amp;srchmode=1">Oncorhynchus
mykiss</a></i> (rainbow trout)</td>
    </tr>
    <tr>
      <td>SIV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Simian+immunodeficiency+virus+&amp;lvl=0&amp;srchmode=1">Simian
immunodeficiency virus</a></i></td>
    </tr>
    <tr>
      <td>SNV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Spleen+necrosis+virus&amp;lvl=0&amp;srchmode=1">Spleen
necrosis virus</a></i></td>
    </tr>
    <tr>
      <td>So</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Spinacia+oleracea&amp;lvl=0&amp;srchmode=1">Spinacia
oleracea</a></i></td>
    </tr>
    <tr>
      <td>Sp</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Strongylocentrotus+purpuratus&amp;lvl=0&amp;srchmode=1">Strongylocentrotus
purpuratus</a></i></td>
    </tr>
    <tr>
      <td>Spe</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Sarcophaga+peregrina&amp;lvl=0&amp;srchmode=1">Sarcophaga
peregrina</a></i></td>
    </tr>
    <tr>
      <td>Sr</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Sesbania+rostrata&amp;lvl=0&amp;srchmode=1">Sesbania
rostrata</a></i></td>
    </tr>
    <tr>
      <td>SRV-1</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Simian+AIDS+retrovirus+SRV-1&amp;lvl=0&amp;srchmode=1">Simian
AIDS retrovirus SRV-1</a></i></td>
    </tr>
    <tr>
      <td>Ss</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Sus+scrofa&amp;lvl=0&amp;srchmode=1">Sus
scrofa</a></i> (pig)</td>
    </tr>
    <tr>
      <td>SSV</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Simian+sarcoma+virus&amp;lvl=0&amp;srchmode=1">Simian
sarcoma virus</a></i></td>
    </tr>
    <tr>
      <td>St</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Solanum+tuberosum&amp;lvl=0&amp;srchmode=1">Solanum
tuberosum</a></i> (potato)</td>
    </tr>
    <tr>
      <td>Sv</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Sorghum+bicolor&amp;lvl=0&amp;srchmode=1">Sorghum
bicolor (sorghum)</a></i></td>
    </tr>
    <tr>
      <td>SV40</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Simian+virus+40&amp;lvl=0&amp;srchmode=1">Simian
virus 40</a></i></td>
    </tr>
    <tr>
      <td>Ta</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Triticum+aestivum&amp;lvl=0&amp;srchmode=1">Triticum
aestivum</a></i> (wheat)</td>
    </tr>
    <tr>
      <td>Visna</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Visna+lentivirus&amp;lvl=0&amp;srchmode=1">Visna
lentivirus</a></i></td>
    </tr>
    <tr>
      <td>Xb</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Xenopus+borealis&amp;lvl=0&amp;srchmode=1">Xenopus
borealis</a></i> (Kenyan clawed frog)</td>
    </tr>
    <tr>
      <td>Xl</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Xenopus+laevis&amp;lvl=0&amp;srchmode=1">Xenopus
laevis</a></i> (African clawed frog)</td>
    </tr>
    <tr>
      <td>Xt</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Xenopus+tropicalis&amp;lvl=0&amp;srchmode=1">Xenopus
tropicalis</a></i> (western clawed frog)</td>
    </tr>
    <tr>
      <td>Zm</td>
      <td><i><a
 href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Undef&amp;name=Zea+mays&amp;lvl=0&amp;srchmode=1">Zea
mays</a></i> (maize)</td>
    </tr>
  </tbody>
</table>
</center>
<a name="JOURNAL_CODES"></a>
<h3 class="subappendix">B.2. JOURNAL CODES</h3>
<center><br>
<table>
  <caption>&nbsp;
  <center>
  <p></p>
  </center>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <th>Code</th>
      <th>Journal name</th>
    </tr>
    <tr>
      <td>ARB</td>
      <td>Annual Review of Biochemistry</td>
    </tr>
    <tr>
      <td>ARP</td>
      <td>Annual Review of Physiology</td>
    </tr>
    <tr>
      <td>BBA</td>
      <td>Biochimica Biophysica Acta</td>
    </tr>
    <tr>
      <td>BBRC</td>
      <td>Biochemical and Biophysical Research Communications</td>
    </tr>
    <tr>
      <td>Bch</td>
      <td>Biochemistry</td>
    </tr>
    <tr>
      <td>Bchi</td>
      <td>Biochimie</td>
    </tr>
    <tr>
      <td>BchJ</td>
      <td>Biochemical Journal</td>
    </tr>
    <tr>
      <td>BCHS</td>
      <td>Biological Chemistry Hoppe-Seyler</td>
    </tr>
    <tr>
      <td>BrJR</td>
      <td>British Journal of Rheumatology</td>
    </tr>
    <tr>
      <td>BrainR</td>
      <td>Brain Research</td>
    </tr>
    <tr>
      <td>Btech</td>
      <td>Biotechnology</td>
    </tr>
    <tr>
      <td>CanR</td>
      <td>Cancer Research</td>
    </tr>
    <tr>
      <td>Cell</td>
      <td>Cell</td>
    </tr>
    <tr>
      <td>CGD</td>
      <td>Cell Growth Differentiation</td>
    </tr>
    <tr>
      <td>Chrom</td>
      <td>Chromosoma</td>
    </tr>
    <tr>
      <td>CSHS</td>
      <td>Cold Spring Harbor Symposia on Quantitative Biology</td>
    </tr>
    <tr>
      <td>CTMI</td>
      <td>Current Topics in Microbiology and Immunology</td>
    </tr>
    <tr>
      <td>CurG</td>
      <td>Current Genetics</td>
    </tr>
    <tr>
      <td>DCB</td>
      <td>DNA and Cell Biology</td>
    </tr>
    <tr>
      <td>DevB</td>
      <td>Developmental Biology</td>
    </tr>
    <tr>
      <td>Diab</td>
      <td>Diabetes</td>
    </tr>
    <tr>
      <td>DNA</td>
      <td>DNA</td>
    </tr>
    <tr>
      <td>ECR</td>
      <td>Experimental Cell Research</td>
    </tr>
    <tr>
      <td>EJBc</td>
      <td>European Journal of Biochemistry</td>
    </tr>
    <tr>
      <td>EJCB</td>
      <td>European Journal of Cellular Biology</td>
    </tr>
    <tr>
      <td>EMBOJ</td>
      <td>EMBO Journal</td>
    </tr>
    <tr>
      <td>EMBOR</td>
      <td>EMBO Reports</td>
    </tr>
    <tr>
      <td>Evo</td>
      <td>Evolution</td>
    </tr>
    <tr>
      <td>FEBS</td>
      <td>FEBS Letters</td>
    </tr>
    <tr>
      <td>GDev</td>
      <td>Genes and Development</td>
    </tr>
    <tr>
      <td>Gene</td>
      <td>Gene</td>
    </tr>
    <tr>
      <td>GChC</td>
      <td>Genes Chromosomes Cancer</td>
    </tr>
    <tr>
      <td>GnmR</td>
      <td>Genome Research</td>
    </tr>
    <tr>
      <td>Gnms</td>
      <td>Genomics</td>
    </tr>
    <tr>
      <td>Gnts</td>
      <td>Genetics</td>
    </tr>
    <tr>
      <td>HGEN</td>
      <td>Human Genetics</td>
    </tr>
    <tr>
      <td>IJCa</td>
      <td>International Journal of Cancer</td>
    </tr>
    <tr>
      <td>ImTo</td>
      <td>Immunology Today</td>
    </tr>
    <tr>
      <td>JBC</td>
      <td>Journal of Biological Chemistry</td>
    </tr>
    <tr>
      <td>JBch</td>
      <td>Journal of Biochemistry</td>
    </tr>
    <tr>
      <td>JCB</td>
      <td>Journal of Cell Biology</td>
    </tr>
    <tr>
      <td>JEM</td>
      <td>Journal of Experimental Medicine</td>
    </tr>
    <tr>
      <td>JGV</td>
      <td>Journal of General Virology</td>
    </tr>
    <tr>
      <td>JI</td>
      <td>Journal of Immunology</td>
    </tr>
    <tr>
      <td>JMAG</td>
      <td>Journal of Molecular and Applied Genetics</td>
    </tr>
    <tr>
      <td>JMB</td>
      <td>Journal of Molecular Biology</td>
    </tr>
    <tr>
      <td>JME</td>
      <td>Journal of Molecular Evolution</td>
    </tr>
    <tr>
      <td>JMEnd</td>
      <td>Journal of Molecular Endocrinology</td>
    </tr>
    <tr>
      <td>JNeSc</td>
      <td>Journal of Neuroscience</td>
    </tr>
    <tr>
      <td>JVir</td>
      <td>Journal of Virology</td>
    </tr>
    <tr>
      <td>MB</td>
      <td>Molecular Biology</td>
    </tr>
    <tr>
      <td>MBE</td>
      <td>Molecular Biology and Evolution</td>
    </tr>
    <tr>
      <td>MBM</td>
      <td>Molecular Biology and Medicine</td>
    </tr>
    <tr>
      <td>MBR</td>
      <td>Molecular Biology Reports</td>
    </tr>
    <tr>
      <td>MCB</td>
      <td>Molecular and Cellular Biology</td>
    </tr>
    <tr>
      <td>MCEnd</td>
      <td>Molecular and Cellular Endocrinology</td>
    </tr>
    <tr>
      <td>MEnd</td>
      <td>Molecular Endocrinology</td>
    </tr>
    <tr>
      <td>MImm</td>
      <td>Molecular Immunology</td>
    </tr>
    <tr>
      <td>MEnz</td>
      <td>Methods in Enzymology</td>
    </tr>
    <tr>
      <td>MGG</td>
      <td>Molecular and General Genetics</td>
    </tr>
    <tr>
      <td>MNeub</td>
      <td>Molecular Neurobiology</td>
    </tr>
    <tr>
      <td>MPMI</td>
      <td>Molecular Plant-Microbe Interactions</td>
    </tr>
    <tr>
      <td>NAR</td>
      <td>Nucleic Acids Research</td>
    </tr>
    <tr>
      <td>Nat</td>
      <td>Nature</td>
    </tr>
    <tr>
      <td>Oncg</td>
      <td>Oncogene</td>
    </tr>
    <tr>
      <td>OncR</td>
      <td>Oncogene Research</td>
    </tr>
    <tr>
      <td>Pla</td>
      <td>Planta</td>
    </tr>
    <tr>
      <td>PlJ</td>
      <td>Plant Journal</td>
    </tr>
    <tr>
      <td>PMB</td>
      <td>Plant Molecular Biology</td>
    </tr>
    <tr>
      <td>PSL</td>
      <td>Plant Science Letters</td>
    </tr>
    <tr>
      <td>RPHR</td>
      <td>Recent Progress in Hormone Research</td>
    </tr>
    <tr>
      <td>PNAS</td>
      <td>Proceedings of the National Academy of Sciences of the United
States
of America</td>
    </tr>
    <tr>
      <td>Sci</td>
      <td>Science</td>
    </tr>
    <tr>
      <td>SCMG</td>
      <td>Somatic Cell and Molecular Genetics</td>
    </tr>
    <tr>
      <td>TiG</td>
      <td>Trends in Genetics</td>
    </tr>
    <tr>
      <td>Vir</td>
      <td>Virology</td>
    </tr>
    <tr>
      <td>VirR</td>
      <td>Virus Research</td>
    </tr>
  </tbody>
</table>
</center>
<a name="ABBREVIATIONS"></a>
<h3 class="subappendix">B.3.&nbsp; ABBREVIATIONS</h3>
<center><br>
<table>
  <caption>&nbsp;
  <center>
  <p></p>
  </center>
  </caption><tbody>
  </tbody><tbody>
  </tbody><tbody>
  </tbody> <tbody>
    <tr>
      <td>1-25OH2D3</td>
      <td>1,25-(OH)_2 vitamin D_3</td>
    </tr>
    <tr>
      <td>20-OHE</td>
      <td>20-Hydroxyecdysone</td>
    </tr>
    <tr>
      <td>4CL</td>
      <td>4-coumarate coenzyme A ligase</td>
    </tr>
    <tr>
      <td>a1</td>
      <td>Gene locus 1 involved in anthocyanin biosynthesis</td>
    </tr>
    <tr>
      <td>abd-g.</td>
      <td>Abdominal ganglion</td>
    </tr>
    <tr>
      <td>abl</td>
      <td>Abelson murine leukemia virus oncogene</td>
    </tr>
    <tr>
      <td>ACC</td>
      <td>1-aminocyclopropane-1-carboxylic acid</td>
    </tr>
    <tr>
      <td>AChR</td>
      <td>Acetylcholin receptor</td>
    </tr>
    <tr>
      <td>ACP</td>
      <td>b'-ketoacyl-acyl carrier protein of fatty acid synthase</td>
    </tr>
    <tr>
      <td>ACTH</td>
      <td>Adrenocorticotropic hormone</td>
    </tr>
    <tr>
      <td>ADA</td>
      <td>Adenosine deaminase</td>
    </tr>
    <tr>
      <td>ADH</td>
      <td>Alcohol dehydrogenase</td>
    </tr>
    <tr>
      <td>ADPg-s</td>
      <td>GT ADPglucose-starch glucosyltransferase</td>
    </tr>
    <tr>
      <td>adult-HA</td>
      <td>Adult hermaphrodite</td>
    </tr>
    <tr>
      <td>AFW1</td>
      <td>Adult fast-white (myosin heavy chain) 1</td>
    </tr>
    <tr>
      <td>Ag</td>
      <td>Antigen</td>
    </tr>
    <tr>
      <td>(AGM)</td>
      <td>"from african green monkey"</td>
    </tr>
    <tr>
      <td>AGP</td>
      <td>Acid glycoprotein</td>
    </tr>
    <tr>
      <td>AGPP</td>
      <td>ADP glucose pyrophosphorylase</td>
    </tr>
    <tr>
      <td>AIRS</td>
      <td>Aminoimidazole ribonucleotide synthase</td>
    </tr>
    <tr>
      <td>ALA-synt.</td>
      <td>5-Aminolevulinate synthase</td>
    </tr>
    <tr>
      <td>ALDH_2</td>
      <td>Aldehyde dehydrogenase 2</td>
    </tr>
    <tr>
      <td>AlkExo</td>
      <td>Alkaline exonuclease</td>
    </tr>
    <tr>
      <td>Amy</td>
      <td>Amylase</td>
    </tr>
    <tr>
      <td>antp</td>
      <td>"antennapedia" locus</td>
    </tr>
    <tr>
      <td>aP2</td>
      <td>Adipocyte homologue of myelin P2</td>
    </tr>
    <tr>
      <td>apolipop.</td>
      <td>Apolipoprotein</td>
    </tr>
    <tr>
      <td>apoVLDLII</td>
      <td>Very low densitiy apolipoprotein II</td>
    </tr>
    <tr>
      <td>APRT</td>
      <td>Adenine phosphoribosyltransferase</td>
    </tr>
    <tr>
      <td>AR</td>
      <td>Adrenergic receptor</td>
    </tr>
    <tr>
      <td>ARF</td>
      <td>ADP-ribosylation factor</td>
    </tr>
    <tr>
      <td>arg</td>
      <td>Arginine</td>
    </tr>
    <tr>
      <td>AS</td>
      <td>Argininosuccinate synthetase</td>
    </tr>
    <tr>
      <td>AS-C</td>
      <td>"achaete-scute" complex locus</td>
    </tr>
    <tr>
      <td>AspAT</td>
      <td>Aspartate aminotransferase</td>
    </tr>
    <tr>
      <td>ass.</td>
      <td>Associated</td>
    </tr>
    <tr>
      <td>AT</td>
      <td>Antitrypsin</td>
    </tr>
    <tr>
      <td>ATIII</td>
      <td>Antithrombin III</td>
    </tr>
    <tr>
      <td>ATCase</td>
      <td>Aspartate transcarbamylase</td>
    </tr>
    <tr>
      <td>ATP</td>
      <td>Adenosinetriphosphate</td>
    </tr>
    <tr>
      <td>awd</td>
      <td>"abnormal wing disk" locus</td>
    </tr>
    <tr>
      <td>BB</td>
      <td>Bowman-Birk (protease inhibitor)</td>
    </tr>
    <tr>
      <td>BCKDHA</td>
      <td>Branched-chain alpha-keto acid dehydrogenase complex</td>
    </tr>
    <tr>
      <td>Bcl-2</td>
      <td>B-cell leukemia/lymphoma 2 proto-oncogene</td>
    </tr>
    <tr>
      <td>BMMC</td>
      <td>Bone marrow-derived mast cell</td>
    </tr>
    <tr>
      <td>BPTI</td>
      <td>Bovine pancreatic trypsin inhibitor</td>
    </tr>
    <tr>
      <td>BSF</td>
      <td>B-cell stimulating factor</td>
    </tr>
    <tr>
      <td>bsg25D</td>
      <td>Blastoderm specific locus 25D</td>
    </tr>
    <tr>
      <td>c-</td>
      <td>Cellular protooncogene ..</td>
    </tr>
    <tr>
      <td>c1</td>
      <td>Regulatory locus of anthocyanin synthesis (maize)</td>
    </tr>
    <tr>
      <td>C4BP</td>
      <td>Complement component C4-binding protein</td>
    </tr>
    <tr>
      <td>CA</td>
      <td>Carbonic anhydrase</td>
    </tr>
    <tr>
      <td>CAD</td>
      <td>Carbamoyl-phosphate synthetase
(glutamine-hydrolysing)/aspartate carbamoyl
transferase/dihydroorotase</td>
    </tr>
    <tr>
      <td>cab</td>
      <td>Chlorophyll a/b-binding protein</td>
    </tr>
    <tr>
      <td>cAMP</td>
      <td>Cyclic AMP (Adenosinemonophosphate)</td>
    </tr>
    <tr>
      <td>card-m.</td>
      <td>Cardiac muscle</td>
    </tr>
    <tr>
      <td>cc-ind.</td>
      <td>Cell cycle-independent</td>
    </tr>
    <tr>
      <td>CD3</td>
      <td>T-cell differentiation antigen CD3</td>
    </tr>
    <tr>
      <td>CD4</td>
      <td>T-cell differentiation antigen CD4</td>
    </tr>
    <tr>
      <td>CD8</td>
      <td>T-cell differentiation antigen CD8</td>
    </tr>
    <tr>
      <td>CEA</td>
      <td>Carcinoembryonic antigen</td>
    </tr>
    <tr>
      <td>CG</td>
      <td>Chorionic gonadotropin</td>
    </tr>
    <tr>
      <td>CNS</td>
      <td>Central nervous system</td>
    </tr>
    <tr>
      <td>CNTF</td>
      <td>Ciliary neurotrophic factor</td>
    </tr>
    <tr>
      <td>car.</td>
      <td>Cartilage</td>
    </tr>
    <tr>
      <td>col.</td>
      <td>Collagen</td>
    </tr>
    <tr>
      <td>conglyc.</td>
      <td>Conglycinin</td>
    </tr>
    <tr>
      <td>cor.</td>
      <td>Cornea</td>
    </tr>
    <tr>
      <td>cotyl.</td>
      <td>Cotyledon</td>
    </tr>
    <tr>
      <td>cp</td>
      <td>Cytoplasm(ic)</td>
    </tr>
    <tr>
      <td>CPS</td>
      <td>Carbamyl-phosphate synthetase</td>
    </tr>
    <tr>
      <td>CRF</td>
      <td>Corticotropin-releasing factor</td>
    </tr>
    <tr>
      <td>CRP</td>
      <td>C-reactive protein</td>
    </tr>
    <tr>
      <td>cs</td>
      <td>Cytosol(ic)</td>
    </tr>
    <tr>
      <td>CSF</td>
      <td>Colony stimulating facter</td>
    </tr>
    <tr>
      <td>cyt</td>
      <td>Cytokinin gene (coding for isopentenyltransferase)</td>
    </tr>
    <tr>
      <td>DAF</td>
      <td>Decay-accelerating factor</td>
    </tr>
    <tr>
      <td>dbp</td>
      <td>DNA binding protein</td>
    </tr>
    <tr>
      <td>DDC</td>
      <td>DOPA decarboxylase</td>
    </tr>
    <tr>
      <td>DDH</td>
      <td>Dihydrodiol dehydrogenase</td>
    </tr>
    <tr>
      <td>dep.</td>
      <td>dependent</td>
    </tr>
    <tr>
      <td>dev.</td>
      <td>Development(ally)</td>
    </tr>
    <tr>
      <td>DHFR</td>
      <td>Dihydrofolate reductase</td>
    </tr>
    <tr>
      <td>diff.</td>
      <td>differentiation, differentiated</td>
    </tr>
    <tr>
      <td>DL/R</td>
      <td>Left and right duplicated region</td>
    </tr>
    <tr>
      <td>dnc</td>
      <td>"dunce" locus</td>
    </tr>
    <tr>
      <td>dUTPase</td>
      <td>Deoxyuridinetriphosphatase</td>
    </tr>
    <tr>
      <td>E</td>
      <td>1. Early, 2. Erythroid cell-specific</td>
    </tr>
    <tr>
      <td>E8</td>
      <td>Ethylene inducible gene during fruit ripening 8</td>
    </tr>
    <tr>
      <td>EAS</td>
      <td>5-epi-aristolochene synthase (sesquiterpene cyclase)</td>
    </tr>
    <tr>
      <td>EBNA</td>
      <td>Epstein-Barr virus nuclear antigens</td>
    </tr>
    <tr>
      <td>ecd-ind.</td>
      <td>Ecdysone-inducible</td>
    </tr>
    <tr>
      <td>EDF</td>
      <td>Eosinophil differentiation factor</td>
    </tr>
    <tr>
      <td>EFW1</td>
      <td>Embryonic fast-white (myosin heavy chain) 1</td>
    </tr>
    <tr>
      <td>EGF</td>
      <td>Epidermal growth factor</td>
    </tr>
    <tr>
      <td>EIa</td>
      <td>Adenovirus early Ia region (transactivating element)</td>
    </tr>
    <tr>
      <td>Eip</td>
      <td>Ecdysone-induced protein</td>
    </tr>
    <tr>
      <td>ELH</td>
      <td>Egg-laying hormone</td>
    </tr>
    <tr>
      <td>em</td>
      <td>Embryo, embryonic</td>
    </tr>
    <tr>
      <td>epithel</td>
      <td>epithelial or epithelium</td>
    </tr>
    <tr>
      <td>EPSP</td>
      <td>5-Enolpyruvylshikimate-3-phosphate</td>
    </tr>
    <tr>
      <td>erbA,B</td>
      <td>(Avian) erythroblastosis virus oncogene A,B</td>
    </tr>
    <tr>
      <td>E-resp.</td>
      <td>Estrogen-responsive</td>
    </tr>
    <tr>
      <td>ERV3</td>
      <td>Endogenous retrovirus 3</td>
    </tr>
    <tr>
      <td>E.Tn</td>
      <td>Early transposon</td>
    </tr>
    <tr>
      <td>et-hypocot.</td>
      <td>Etiolated hypocotyl</td>
    </tr>
    <tr>
      <td>ev1</td>
      <td>(Avian) endogenous virus 1</td>
    </tr>
    <tr>
      <td>eve</td>
      <td>"even-skipped" locus</td>
    </tr>
    <tr>
      <td>exch.</td>
      <td>Exchanger</td>
    </tr>
    <tr>
      <td>f.</td>
      <td>Factor</td>
    </tr>
    <tr>
      <td>fib.</td>
      <td>Fibers</td>
    </tr>
    <tr>
      <td>fibrob.</td>
      <td>Fibroblasts</td>
    </tr>
    <tr>
      <td>FMRFamide</td>
      <td>Phe-Met-Arg-Phe-NH(2) neuropeptide</td>
    </tr>
    <tr>
      <td>FNR</td>
      <td>Ferredoxin-(NADP+)-oxidoreductase</td>
    </tr>
    <tr>
      <td>FBP</td>
      <td>Folate Binding Protein</td>
    </tr>
    <tr>
      <td>fos</td>
      <td>FBJ (Finkel-Biskis-Jinkins) osteosarcoma virus oncogene</td>
    </tr>
    <tr>
      <td>FSH</td>
      <td>Follicle stimulating hormone</td>
    </tr>
    <tr>
      <td>ftz</td>
      <td>"fushi tarazu" locus</td>
    </tr>
    <tr>
      <td>g.</td>
      <td>Gene</td>
    </tr>
    <tr>
      <td>G0S..</td>
      <td>G0/G1 switch regulatory gene ..</td>
    </tr>
    <tr>
      <td>G6PD</td>
      <td>Glucose-6-phosphate dehydrogenase</td>
    </tr>
    <tr>
      <td>GA</td>
      <td>Gibberellic acid</td>
    </tr>
    <tr>
      <td>GADPH</td>
      <td>Glyceraldehyde-3-phosphate dehydrogenase</td>
    </tr>
    <tr>
      <td>GARS</td>
      <td>Glycinamide ribonucleotide synthase</td>
    </tr>
    <tr>
      <td>Gart</td>
      <td>"Gart" locus (-&gt; GARS, AIRS, GART)</td>
    </tr>
    <tr>
      <td>GART</td>
      <td>Glycinamide ribonucleotide transformylase</td>
    </tr>
    <tr>
      <td>gC</td>
      <td>Glycoprotein C</td>
    </tr>
    <tr>
      <td>G-CSF</td>
      <td>Granulocyte colony stimulating factor</td>
    </tr>
    <tr>
      <td>gD</td>
      <td>Glycoprotein D</td>
    </tr>
    <tr>
      <td>GdX</td>
      <td>X-linked gene downstream of G6PD gene</td>
    </tr>
    <tr>
      <td>gE</td>
      <td>Glycoprotein E</td>
    </tr>
    <tr>
      <td>GFAP</td>
      <td>Glial fibrillary acidic protein</td>
    </tr>
    <tr>
      <td>g'GT</td>
      <td>g'-Glutamyl transpeptidase</td>
    </tr>
    <tr>
      <td>gln</td>
      <td>Glutamine</td>
    </tr>
    <tr>
      <td>globul-12s</td>
      <td>12s globulin (oat seed storage protein)</td>
    </tr>
    <tr>
      <td>glucc</td>
      <td>Glucocorticoid</td>
    </tr>
    <tr>
      <td>GLUT1</td>
      <td>Glucose transporter type 1</td>
    </tr>
    <tr>
      <td>GM-CSF</td>
      <td>Granulocyte/Macrophage colony stimulating factor</td>
    </tr>
    <tr>
      <td>GnRH</td>
      <td>Gonadotropin-releasing hormone</td>
    </tr>
    <tr>
      <td>gp</td>
      <td>Glycoprotein</td>
    </tr>
    <tr>
      <td>GPD</td>
      <td>Glycerol-3-phosphate dehydrogenase</td>
    </tr>
    <tr>
      <td>GPT</td>
      <td>UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1-phosphate
transferase</td>
    </tr>
    <tr>
      <td>granulo-c</td>
      <td>Granulocyte</td>
    </tr>
    <tr>
      <td>GRF</td>
      <td>Growth hormone-releasing factor</td>
    </tr>
    <tr>
      <td>GRP</td>
      <td>Glycine-rich (cell wall) protein</td>
    </tr>
    <tr>
      <td>GS17</td>
      <td>Gastrula-specific transcript 17</td>
    </tr>
    <tr>
      <td>GSHPx</td>
      <td>Gluthathione peroxidase</td>
    </tr>
    <tr>
      <td>G-spec.</td>
      <td>Gastrula-specific</td>
    </tr>
    <tr>
      <td>GST</td>
      <td>Gutathione S-transferase</td>
    </tr>
    <tr>
      <td>H</td>
      <td>1. Heavy chain, 2. Housekeeping-type promoter</td>
    </tr>
    <tr>
      <td>Ha-ras</td>
      <td>Rat-derived Harvey murine sarcoma virus oncogene</td>
    </tr>
    <tr>
      <td>haptoblob</td>
      <td>haptoglobin</td>
    </tr>
    <tr>
      <td>hb</td>
      <td>"hunchbank" locus</td>
    </tr>
    <tr>
      <td>Hc</td>
      <td>High-cysteine (chorion protein)</td>
    </tr>
    <tr>
      <td>HDC</td>
      <td>L-histidine decarboxylase</td>
    </tr>
    <tr>
      <td>hematop.</td>
      <td>hematopoietic</td>
    </tr>
    <tr>
      <td>HGT</td>
      <td>High-(glycine+tyrosine) keratin</td>
    </tr>
    <tr>
      <td>hist.</td>
      <td>Histone</td>
    </tr>
    <tr>
      <td>HMG-</td>
      <td>High mobility group chromosomal protein</td>
    </tr>
    <tr>
      <td>HMG-CoA</td>
      <td>3-Hydroxy-3-methylglutaryl coenzyme A</td>
    </tr>
    <tr>
      <td>HPRT</td>
      <td>Hypoxanthine phosphoribosyltransferase</td>
    </tr>
    <tr>
      <td>hs</td>
      <td>Heatshock</td>
    </tr>
    <tr>
      <td>hsc</td>
      <td>Constitutive analogue of heatshock gene/protein</td>
    </tr>
    <tr>
      <td>HSF</td>
      <td>Hepatocyte-stimulating factor</td>
    </tr>
    <tr>
      <td>hsp</td>
      <td>Heatshock protein</td>
    </tr>
    <tr>
      <td>Ht</td>
      <td>Testicular histone</td>
    </tr>
    <tr>
      <td>HTF</td>
      <td>Restriction endonuclease HpaII tiny fragments</td>
    </tr>
    <tr>
      <td>I-FABP</td>
      <td>Intestinal fatty-acid binding protein</td>
    </tr>
    <tr>
      <td>IAA</td>
      <td>Indolacetic acid</td>
    </tr>
    <tr>
      <td>IAP</td>
      <td>Intracisternal A-particles</td>
    </tr>
    <tr>
      <td>ICP</td>
      <td>Infected cell protein</td>
    </tr>
    <tr>
      <td>IE</td>
      <td>Immediate early (gene, RNA)</td>
    </tr>
    <tr>
      <td>IF</td>
      <td>Intermediate filament</td>
    </tr>
    <tr>
      <td>IFI</td>
      <td>Interferon-induced gene/protein</td>
    </tr>
    <tr>
      <td>IFN</td>
      <td>Interferon</td>
    </tr>
    <tr>
      <td>Ig</td>
      <td>Immunoglobulin</td>
    </tr>
    <tr>
      <td>IGF</td>
      <td>Insulin-like growth factor</td>
    </tr>
    <tr>
      <td>IL</td>
      <td>Interleukin</td>
    </tr>
    <tr>
      <td>inf.</td>
      <td>Infected</td>
    </tr>
    <tr>
      <td>inh.</td>
      <td>Inhibitor</td>
    </tr>
    <tr>
      <td>iNOS</td>
      <td>Inducible nitric oxide synthase</td>
    </tr>
    <tr>
      <td>IRF</td>
      <td>Interferon regulatory factor</td>
    </tr>
    <tr>
      <td>ISG</td>
      <td>Interferon-stimulated gene</td>
    </tr>
    <tr>
      <td>k.</td>
      <td>Kinase</td>
    </tr>
    <tr>
      <td>keratino-c</td>
      <td>Keratinocyte</td>
    </tr>
    <tr>
      <td>Ki-ras</td>
      <td>Rat-derived Kirsten murine sarcoma virus oncogene</td>
    </tr>
    <tr>
      <td>L</td>
      <td>1. Light chain; 2. Late</td>
    </tr>
    <tr>
      <td>larva-1,2,..</td>
      <td>First, second, .. instar larva</td>
    </tr>
    <tr>
      <td>LAT..</td>
      <td>Lycopersicon anther-specific gene ..</td>
    </tr>
    <tr>
      <td>LCAT</td>
      <td>Lecithin-cholesterol acyltransferase</td>
    </tr>
    <tr>
      <td>lck</td>
      <td>T-cell- or lymphocyte-specific tyrosine kinase</td>
    </tr>
    <tr>
      <td>LDH</td>
      <td>Lactate dehydrogenase</td>
    </tr>
    <tr>
      <td>leghem.</td>
      <td>Leghemoglobin</td>
    </tr>
    <tr>
      <td>LeIF</td>
      <td>Leukocyte interferon</td>
    </tr>
    <tr>
      <td>leuko-c</td>
      <td>Leukocyte</td>
    </tr>
    <tr>
      <td>LH</td>
      <td>Luteinizing hormone</td>
    </tr>
    <tr>
      <td>LHC</td>
      <td>Light-harvesting complex</td>
    </tr>
    <tr>
      <td>LHRH</td>
      <td>Luteinizing hormone-releasing factor</td>
    </tr>
    <tr>
      <td>liv.</td>
      <td>liver</td>
    </tr>
    <tr>
      <td>LMW</td>
      <td>Low molecular weight</td>
    </tr>
    <tr>
      <td>LPH</td>
      <td>Lipotropic hormone</td>
    </tr>
    <tr>
      <td>LPS</td>
      <td>Lipopolysaccharide</td>
    </tr>
    <tr>
      <td>LTR</td>
      <td>Long Terminal Repeat</td>
    </tr>
    <tr>
      <td>lympho-c</td>
      <td>Lymphocyte</td>
    </tr>
    <tr>
      <td>lys</td>
      <td>Lysosomal</td>
    </tr>
    <tr>
      <td>MBP</td>
      <td>Myelin basic protein</td>
    </tr>
    <tr>
      <td>(MAC)</td>
      <td>Macaque</td>
    </tr>
    <tr>
      <td>MC</td>
      <td>Methylcholanthrene</td>
    </tr>
    <tr>
      <td>MCK</td>
      <td>Muscle-specific creatine kinase</td>
    </tr>
    <tr>
      <td>mGK</td>
      <td>Submaxillary gland kallikrein</td>
    </tr>
    <tr>
      <td>MHCI/MHCII</td>
      <td>Class I/II transplantation antigens of major
histocompatibility complex</td>
    </tr>
    <tr>
      <td>MIF</td>
      <td>Macrophage migration inhibitory factor</td>
    </tr>
    <tr>
      <td>minipara</td>
      <td>Miniparamyosin</td>
    </tr>
    <tr>
      <td>mit</td>
      <td>Mitochondrial</td>
    </tr>
    <tr>
      <td>mono-c</td>
      <td>Monocyte</td>
    </tr>
    <tr>
      <td>mononuc-c.</td>
      <td>Mononuclear cells</td>
    </tr>
    <tr>
      <td>MOPC..</td>
      <td>Mineral oil-induced plasmacytoma</td>
    </tr>
    <tr>
      <td>mos</td>
      <td>Moloney murine sarcoma virus oncogene</td>
    </tr>
    <tr>
      <td>MP</td>
      <td>Macrophage</td>
    </tr>
    <tr>
      <td>MPC..</td>
      <td>Mouse plasma cell tumor</td>
    </tr>
    <tr>
      <td>MRP</td>
      <td>MIF-related protein (see MIF)</td>
    </tr>
    <tr>
      <td>MSF</td>
      <td>Megakaryocyte stimulating factor</td>
    </tr>
    <tr>
      <td>msp</td>
      <td>Major sperm protein gene</td>
    </tr>
    <tr>
      <td>MT</td>
      <td>Metallothionein</td>
    </tr>
    <tr>
      <td>mst</td>
      <td>Male-specific transcript</td>
    </tr>
    <tr>
      <td>MUP</td>
      <td>Major urinary protein</td>
    </tr>
    <tr>
      <td>myb</td>
      <td>(Avian) myeoloblastosis virus oncogene</td>
    </tr>
    <tr>
      <td>myc</td>
      <td>Myelocytomatosis virus 29 oncogene</td>
    </tr>
    <tr>
      <td>NCA</td>
      <td>nonspecific cross-reacting (with -&gt; CEA) antigen</td>
    </tr>
    <tr>
      <td>nerv. sys</td>
      <td>Nervous system</td>
    </tr>
    <tr>
      <td>neu</td>
      <td>Ethyl-nitrosurea-induced rat neuroblastoma oncogene</td>
    </tr>
    <tr>
      <td>neuropep.</td>
      <td>Neuropeptide</td>
    </tr>
    <tr>
      <td>NGF</td>
      <td>Nerve growth factor</td>
    </tr>
    <tr>
      <td>ninaE</td>
      <td>"neither inactivation nor afterpotential" locus E</td>
    </tr>
    <tr>
      <td>NMDH</td>
      <td>NADP-malate dehydrogenase</td>
    </tr>
    <tr>
      <td>NOS</td>
      <td>Nitric oxide synthase</td>
    </tr>
    <tr>
      <td>nos</td>
      <td>Nopaline synthetase</td>
    </tr>
    <tr>
      <td>NR</td>
      <td>Nitrate reductase</td>
    </tr>
    <tr>
      <td>N-ras</td>
      <td>Neuroblastoma ras-like (-&gt; Ha-ras) oncogene</td>
    </tr>
    <tr>
      <td>NS</td>
      <td>Nervous system</td>
    </tr>
    <tr>
      <td>OAT</td>
      <td>Ornithine aminotransferase</td>
    </tr>
    <tr>
      <td>ocs</td>
      <td>Octopine synthetase</td>
    </tr>
    <tr>
      <td>ODC</td>
      <td>Ornithine decarboxylase</td>
    </tr>
    <tr>
      <td>Ori</td>
      <td>Origin of replication</td>
    </tr>
    <tr>
      <td>OTC</td>
      <td>Ornithine transcarbamylase</td>
    </tr>
    <tr>
      <td>ovalb.</td>
      <td>Ovalbumin</td>
    </tr>
    <tr>
      <td>p.</td>
      <td>Protein</td>
    </tr>
    <tr>
      <td>P-450</td>
      <td>Cytochrome P-450</td>
    </tr>
    <tr>
      <td>p53</td>
      <td>53K phosphoprotein</td>
    </tr>
    <tr>
      <td>panc.</td>
      <td>pancreas, pancreatic</td>
    </tr>
    <tr>
      <td>parath.</td>
      <td>Parathyroid</td>
    </tr>
    <tr>
      <td>PB</td>
      <td>Phenobarbital</td>
    </tr>
    <tr>
      <td>PBGD</td>
      <td>Porphobilinogen deaminase</td>
    </tr>
    <tr>
      <td>PCNA</td>
      <td>Proliferating cell nuclear antigen</td>
    </tr>
    <tr>
      <td>PDEase</td>
      <td>cAMP phosphodiesterase</td>
    </tr>
    <tr>
      <td>PDGF</td>
      <td>Platelet-derived growth factor</td>
    </tr>
    <tr>
      <td>PEPCase</td>
      <td>Phosphoenolpyruvate carboxylase</td>
    </tr>
    <tr>
      <td>PEPCK</td>
      <td>Phosphoenolpyruvate carboxykinase</td>
    </tr>
    <tr>
      <td>PG</td>
      <td>Prostaglandin</td>
    </tr>
    <tr>
      <td>PGK</td>
      <td>3-Phosphoglycerate kinase</td>
    </tr>
    <tr>
      <td>PHA</td>
      <td>Phytohemagglutinin</td>
    </tr>
    <tr>
      <td>PK</td>
      <td>Protein kinase</td>
    </tr>
    <tr>
      <td>P_L</td>
      <td>Late promoter</td>
    </tr>
    <tr>
      <td>PLP</td>
      <td>Proteolipid protein</td>
    </tr>
    <tr>
      <td>POL</td>
      <td>Polymerase</td>
    </tr>
    <tr>
      <td>POMC</td>
      <td>Proopiomelanocortin</td>
    </tr>
    <tr>
      <td>pp..</td>
      <td>Phosphoprotein ..</td>
    </tr>
    <tr>
      <td>PR1a</td>
      <td>Pathogenesis-related protein 1a</td>
    </tr>
    <tr>
      <td>PRBP</td>
      <td>Plasma retinol-binding protein</td>
    </tr>
    <tr>
      <td>PRL</td>
      <td>Prolactin</td>
    </tr>
    <tr>
      <td>prog.</td>
      <td>Progesterone</td>
    </tr>
    <tr>
      <td>prolyl</td>
      <td>4-hydr. Prolyl 4-hydroxylase</td>
    </tr>
    <tr>
      <td>PrP</td>
      <td>Prion protein</td>
    </tr>
    <tr>
      <td>PSG1,PSG2,.</td>
      <td>Pregnancy-specific glycoproteins 1,2,.</td>
    </tr>
    <tr>
      <td>PSBP</td>
      <td>Prostatic steroid binding protein</td>
    </tr>
    <tr>
      <td>PSP</td>
      <td>Parotid secretory protein</td>
    </tr>
    <tr>
      <td>PTH</td>
      <td>Parathyroid hormone</td>
    </tr>
    <tr>
      <td>pTiN</td>
      <td>Nopaline type tumor inducing plasmid</td>
    </tr>
    <tr>
      <td>pTiO</td>
      <td>Octopine type tumor inducing plasmid</td>
    </tr>
    <tr>
      <td>r</td>
      <td>"rudimentary" locus</td>
    </tr>
    <tr>
      <td>R</td>
      <td>1. Regulatory subunit, 2. Erythroid cell-specific</td>
    </tr>
    <tr>
      <td>RAB</td>
      <td>Gene responsive to ABA</td>
    </tr>
    <tr>
      <td>ras</td>
      <td>Homologue of -&gt; Ha-ras, Ki-ras, etc.</td>
    </tr>
    <tr>
      <td>rec.</td>
      <td>Receptor</td>
    </tr>
    <tr>
      <td>red.</td>
      <td>Reductase</td>
    </tr>
    <tr>
      <td>reg.</td>
      <td>Regulated</td>
    </tr>
    <tr>
      <td>rep-dep.</td>
      <td>Replication-dependent</td>
    </tr>
    <tr>
      <td>rig</td>
      <td>Rat insulinoma gene</td>
    </tr>
    <tr>
      <td>RnBP</td>
      <td>Renin-binding protein</td>
    </tr>
    <tr>
      <td>RNR1,</td>
      <td>RNR2 Ribonucleotide reductase large, small subunit</td>
    </tr>
    <tr>
      <td>rp</td>
      <td>Ribosomal protein</td>
    </tr>
    <tr>
      <td>rTn</td>
      <td>Retrotransposon</td>
    </tr>
    <tr>
      <td>RuBPCss</td>
      <td>Ribulose-1,5-biphosphate carboxylase small subunit</td>
    </tr>
    <tr>
      <td>RuBPCA</td>
      <td>Ribulose-1,5-biphosphate carboxylase/oxygenase activase</td>
    </tr>
    <tr>
      <td>s.</td>
      <td>Small</td>
    </tr>
    <tr>
      <td>saliv-g.</td>
      <td>Salivary gland</td>
    </tr>
    <tr>
      <td>SBP</td>
      <td>Spermine-binding protein</td>
    </tr>
    <tr>
      <td>SC</td>
      <td>Stem cells</td>
    </tr>
    <tr>
      <td>sem-v.</td>
      <td>Seminal vesicle</td>
    </tr>
    <tr>
      <td>ser.</td>
      <td>Serum</td>
    </tr>
    <tr>
      <td>sgs</td>
      <td>Salivary gland secretion protein</td>
    </tr>
    <tr>
      <td>sis</td>
      <td>Simian sarcoma virus oncogene</td>
    </tr>
    <tr>
      <td>sk-m.</td>
      <td>Skeletal muscle</td>
    </tr>
    <tr>
      <td>skel-m.</td>
      <td>Skeletal muscle</td>
    </tr>
    <tr>
      <td>smooth-m.</td>
      <td>Smooth muscle</td>
    </tr>
    <tr>
      <td>snRNA</td>
      <td>Small nuclear RNA</td>
    </tr>
    <tr>
      <td>snRNA</td>
      <td>Small nuclear ribonucleoprotein</td>
    </tr>
    <tr>
      <td>SOD</td>
      <td>Superoxide dismutase</td>
    </tr>
    <tr>
      <td>som</td>
      <td>Somatic</td>
    </tr>
    <tr>
      <td>spat-reg.</td>
      <td>Spatially regulated</td>
    </tr>
    <tr>
      <td>Spec</td>
      <td>Strongylocentrotus purpureatus ectoderm enriched RNA</td>
    </tr>
    <tr>
      <td>SPI</td>
      <td>Serine protease inhibitor</td>
    </tr>
    <tr>
      <td>sry</td>
      <td>"serendipity" locus</td>
    </tr>
    <tr>
      <td>SV40T</td>
      <td>Tumor antigen of simian virus 40 (SV40)</td>
    </tr>
    <tr>
      <td>SVS</td>
      <td>Seminal vesicle secretory protein</td>
    </tr>
    <tr>
      <td>synt.</td>
      <td>Synthase</td>
    </tr>
    <tr>
      <td>T3d'</td>
      <td>T-cell antigen receptor-associated T3-complex delta chain</td>
    </tr>
    <tr>
      <td>TAT</td>
      <td>Tyrosine aminotransferase</td>
    </tr>
    <tr>
      <td>TCDD</td>
      <td>2,3,7,8-Tetrachlorodibenzo-p-dioxin</td>
    </tr>
    <tr>
      <td>TCGF</td>
      <td>T-cell growth factor</td>
    </tr>
    <tr>
      <td>TCR</td>
      <td>T-cell receptor</td>
    </tr>
    <tr>
      <td>TdT</td>
      <td>Terminal deoxynucleotidyltransferase</td>
    </tr>
    <tr>
      <td>test.</td>
      <td>testis</td>
    </tr>
    <tr>
      <td>TF</td>
      <td>Transcription factor</td>
    </tr>
    <tr>
      <td>TGA1a</td>
      <td>TGACG-specific DNA-binding protein 1a</td>
    </tr>
    <tr>
      <td>TGF-b'</td>
      <td>Transforming growth factor beta</td>
    </tr>
    <tr>
      <td>TH</td>
      <td>Tyrosin hydroxylase</td>
    </tr>
    <tr>
      <td>thyr.</td>
      <td>Thyroxine</td>
    </tr>
    <tr>
      <td>Thy-1.2</td>
      <td>Thy-1 (thymocyte) antigen/glycoprotein allotype 2</td>
    </tr>
    <tr>
      <td>TIF</td>
      <td>Trans-inducing factor</td>
    </tr>
    <tr>
      <td>TIM</td>
      <td>Triosephosphate isomerase</td>
    </tr>
    <tr>
      <td>tis.</td>
      <td>Tissue</td>
    </tr>
    <tr>
      <td>TM</td>
      <td>Tropomyosin</td>
    </tr>
    <tr>
      <td>tmr</td>
      <td>"tumor morphology root" locus</td>
    </tr>
    <tr>
      <td>TNF</td>
      <td>Tumor necrosis factor</td>
    </tr>
    <tr>
      <td>TnI</td>
      <td>Troponin I (inhibitory subunit)</td>
    </tr>
    <tr>
      <td>TnT</td>
      <td>Troponin T (tropomyosin-binding subunit)</td>
    </tr>
    <tr>
      <td>TO</td>
      <td>Tryptophan oxygenase</td>
    </tr>
    <tr>
      <td>TP1,TP2,.</td>
      <td>Transition protein 1,2,.</td>
    </tr>
    <tr>
      <td>TPA</td>
      <td>12-O-tetradecaonyl-phorbol-13-acetate</td>
    </tr>
    <tr>
      <td>TPI</td>
      <td>Triosephosphate isomerase</td>
    </tr>
    <tr>
      <td>tr.,tr-</td>
      <td>Transcript</td>
    </tr>
    <tr>
      <td>TRF</td>
      <td>T-cell replacing factor</td>
    </tr>
    <tr>
      <td>TRH</td>
      <td>Thyrotropin-releasing hormone</td>
    </tr>
    <tr>
      <td>TS</td>
      <td>Thymidylate sythetase</td>
    </tr>
    <tr>
      <td>TSH</td>
      <td>Thyroid stimulating hormone</td>
    </tr>
    <tr>
      <td>T/t</td>
      <td>Large/small T(tumor) antigen</td>
    </tr>
    <tr>
      <td>Ubx</td>
      <td>"ultrabithorax" locus</td>
    </tr>
    <tr>
      <td>uPA</td>
      <td>Urine plasminogen activator</td>
    </tr>
    <tr>
      <td>URO-D</td>
      <td>Uroporphyrinogen decarboxylase</td>
    </tr>
    <tr>
      <td>Vg1</td>
      <td>Vegetal hemisphere-specific mRNA 1</td>
    </tr>
    <tr>
      <td>vir-inf.</td>
      <td>Viral infection</td>
    </tr>
    <tr>
      <td>VL30</td>
      <td>Retrovirus-like 30s RNA</td>
    </tr>
    <tr>
      <td>VLDL</td>
      <td>Very low density lipoprotein</td>
    </tr>
    <tr>
      <td>V_NP</td>
      <td>(Immunoglobulin heavy chain) variable region specific for
4-hydroxyl-3-nitrophenacetyl</td>
    </tr>
    <tr>
      <td>VP5</td>
      <td>Virion protein 5 (HSV-1/2: =major capsid protein)</td>
    </tr>
    <tr>
      <td>VSP</td>
      <td>Virion stimulatory protein</td>
    </tr>
    <tr>
      <td>vWf</td>
      <td>von Willebrand factor</td>
    </tr>
    <tr>
      <td>Zen</td>
      <td>"zerknuellt" protein</td>
    </tr>
  </tbody>
</table>
</center>
</div> <!-- sib_body -->
</font>

</body>
</html>
